C0000039|A4222344|AT22533916|satauiVal|MSH|Synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of PULMONARY SURFACTANTS.|N|cvfVal|
C0000097|A3132224|AT21447910||CSP|1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a toxic contaminant found in the abused drug methylenedioxymethamphetamine ("ecstasy") which causes Parkinsonlike symptoms.|N||
C0000097|A3654436|AT22515882||MSH|A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.|N||
C0000194|A3918007|AT22531981||MSH|A reagent used for the determination of iron.|N||
C0000530|A2736327|AT18327121||NCI|A class of enzymes present in various organs and in many cells that catalyze the hydrolysis of a 5'-ribonucleotide to a ribonucleoside and orthophosphate in the presence of water. Serum 5'-N'Tase is measured as an indicator of liver damage resulting primarily from interference with the secretion of bile. Serum 5'-N'Tase is not as sensitive as some other enzymes (for example, ALP, AST, and ALT) to liver damage, but it is a more liver-specific enzyme. The level of this enzyme parallels alkaline phosphatase (ALP). It is used mostly to differentiate elevations in the above enzymes due to liver damage from damage to skeletal muscle.|N||
C0000530|A4335943|AT22530059||MSH|A glycoprotein enzyme present in various organs and in many cells. The enzyme catalyzes the hydrolysis of a 5'-ribonucleotide to a ribonucleoside and orthophosphate in the presence of water. It is cation-dependent and exists in a membrane-bound and soluble form. EC 3.1.3.5.|N||
C0000726|A2577067|AT49954729||UWDA|Subdivision of trunk, which is demarcated from the thorax internally by the inferior surface of the sternocostal part of the diaphragm and externally by the costal margin, from the pelvis by the plane of the superior pelvic aperture and from the lower limbs by the inguinal folds; together with the thorax, pelvis, and perineum, it constitutes the trunk. Examples: There is only one abdomen.|N||
C0000726|A2744428|AT18505685||NCI-GLOSS|(AB-do-men) The area of the body that contains the pancreas, stomach, intestine, liver, gallbladder, and other organs.|N||
C0000726|A2744552|AT56566910||NCI|The portion of the body that lies between the thorax and the pelvis.|N||
C0000726|A2744662|AT18505591||NCI-GLOSS|Having to do with the abdomen, which is the part of the body between the chest and the hips that contains the pancreas, stomach, intestines, liver, gallbladder, and other organs.|N||
C0000726|A2744664|AT18334880||NCI|Of, or related to, the abdomen.|N||
C0000726|A4426704|AT21442518||CSP|portion of the body that lies between the thorax and the pelvis.|N||
C0000726|A4426710|AT22531842||MSH|That portion of the body that lies between the THORAX and the PELVIS.|N||
C0000726|A8684631|AT60861156||CDISC|The portion of the body that lies between the thorax and the pelvis. (NCI)|N||
C0000737|A4533202|AT22523446||MSH|Sensation of discomfort, distress, or agony in the abdominal region; generally associated with functional disorders, tissue injuries, or diseases.|N||
C0000769|A5678651|AT22536427||MSH|Used with organs for congenital defects producing changes in the morphology of the organ. It is used also for abnormalities in animals.|N||
C0000780|A2839523|AT22528949||MSH|The fourth stomach of ruminating animals. It is also called the "true" stomach. It is an elongated pear-shaped sac lying on the floor of the abdomen, on the right-hand side, and roughly between the seventh and twelfth ribs. It leads to the beginning of the small intestine. (From Black's Veterinary Dictionary, 17th ed)|N||
C0000979|A2981860|AT21443896||CSP|salts or esters of acetic acid in which the terminal hydrogen atom is replaced by a metal, for instance copper acetate Cu(CH3COO)2, or where substitution is by a radical, for instance ethyl acetate CH3COOC2H5.|N||
C0000979|A2987380|AT22531047||MSH|Salts or esters of acetic acid in which the terminal hydrogen atom is replaced by a metal, for instance copper acetate Cu(CH3COO)2, or where substitution is by a radical, for instance ethyl acetate CH3COOC2H5. (From Hawley's Condensed Chemical Dictionary, 12th ed)|N||
C0001109|A3025591|AT22520974||MSH|An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2.|N||
C0001555|A5703273|AT22515086||MSH|Used with drugs for dosage forms, routes of administration, frequency and duration of administration, quantity of medication, and the effects of these factors.|N||
C0001688|A5717256|AT22518875||MSH|Used with drugs, chemicals, or biological agents in accepted dosage - or with physical agents or manufactured products in normal usage - when intended for diagnostic, therapeutic, prophylactic, or anesthetic purposes. It is used also for adverse effects or complications of diagnostic, therapeutic, prophylactic, anesthetic, surgical, or other procedures, but excludes contraindications for which "contraindications" is used.|N||
C0002059|A0912500|AT49915346||SPN|A leukocyte alkaline phosphatase test is a device used to identify the enzyme leukocyte alkaline phosphatase in neutrophilic granulocytes (granular leukocytes stainable by neutral dyes). The cytochemical identification of alkaline phosphatase depends on the formation of blue granules in cells containing alkaline phosphatase. The results of this test are used to differentiate chronic granulocytic leukemia (a malignant disease characterized by excessive overgrowth of granulocytes in the bone marrow) and reactions that resemble true leukemia, such as those occuring in severe infections and polycythemia (increased total red cell mass).|N||
C0002059|A2674070|AT43122608||NCI|An enzyme that catalyses the cleavage of inorganic phosphate non-specifically from a wide variety of phosphate esters and having a high (greater than 8) pH optimum.|N||
C0002059|A3392348|AT22519156||MSH|An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.|N||
C0002526|A2684784|AT18488254||NCI|Amino acids and chains of amino acids connected by peptide linkages.|N||
C0002526|A3570665|AT22526319||MSH|Amino acids and chains of amino acids connected by peptide linkages.|N||
C0002776|A5772371|AT22534830||MSH|Used with drugs and chemicals for substances that share the same parent molecule or have similar electronic structure but differ by the addition or substitution of other atoms or molecules. It is used when the specific chemical heading is not available and no appropriate group heading exists.|N||
C0003139|A2951485|AT21448852||CSP|antagonist is any agent which blocks, inhibits, or attenuates the pharmacological action of another agent; can be indexed with other agent or receptor terms to cover specific antagonist types when a specific precoordinated term is not available.|N||
C0003139|A5789728|AT22519889||MSH|Used with chemicals, drugs, and endogenous substances to indicate substances or agents which counteract their biological effects by any mechanism.|N||
C0003322|A3864660|AT22533972||MSH|Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.|N||
C0003322|A4077349|AT21449244||CSP|differentiation antigens (markers) of lymphocyte subsets on cell membrane which are defined by monoclonal antibodies.|N||
C0003322|A8897623|AT63367332||NCI|A designation for cell surface molecules present on leukocytes.|N||
C0003323|A2719955|AT18325966||NCI|CD4 Antigen, encoded by the CD4 gene, is a T-cell surface glycoprotein. CD4 has a role in cell-cell interactions and may act in signal transduction. CD4 is a accessory protein for MHC class-II antigen/T-cell receptor interaction and functions to initiate or augment the early phase of T-cell activation. CD4 enhances T-cell sensitivity to antigen and binds to LCK, which phosphorylates CD3-zeta. CD4 Antigen also serves as an HIV receptor, binding directly to the envelope protein gp120 on HIV. (From LocusLink, OMIM and NCI)|N||
C0003323|A3864388|AT55405074||MSH|55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. CD4 antigens are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. CD4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120.|N||
C0003323|A4076745|AT21449524||CSP|helper T-lymphocyte marker that functions as a receptor for MHC class II antigen; also acts as the receptor for HIV.|N||
C0005572|A3994490|AT22523299||MSH|Used for the anabolic formation of chemical substances in organisms, in living cells, or by subcellular fractions.|N||
C0005768|A4003364|AT22521315||MSH|Used for the presence or analysis of substances in the blood; also for examination of, or changes in, the blood in disease states. It excludes serodiagnosis, for which the subheading "diagnosis" is used, and serology, for which "immunology" is used.|N||
C0005839|A4010435|AT22519158||MSH|Used for arterial, capillary, and venous systems of an organ or region whenever the specific heading for the vessel does not exist. It includes blood flow through the organ.|N||
C0007004|A2717384|AT18544700||NCI|The largest class of organic compounds, including starches, glycogens, cellulose, gums, and simple sugars. Carbohydrates are composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. (MeSH)|N||
C0007004|A4059058|AT22524832||MSH|The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrates are composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n.|N||
C0007004|A4066823|AT21448660||CSP|largest class of organic compounds, including starches, glycogens, cellulose, gums, and simple sugars; carbohydrates are composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n.|N||
C0007807|A4091404|AT22521564||MSH|Used for the presence or analysis of substances in the cerebrospinal fluid; also for examination of or changes in cerebrospinal fluid in disease states.|N||
C0007965|A2722258|AT43089166||NCI|A rare autosomal recessive immunodeficiency disorder characterized by abnormal intracellular protein transport. Chediak-Higashi syndrome (CHS) is characterized by immune deficiency; partial oculocutaneous albinism; a bleeding disorder due to deficient platelet dense bodies; neutropenia; neutrophils with impaired chemotaxis and bactericidal activity; recurrent infection; and abnormal natural killer (NK) cell function. CHS may be associated with hepatosplenomegaly, lymphadenopathy, anemia, thrombocytopenia, roentgenologic changes in bones, lungs and heart, and skin and psychomotor abnormalities; it is often fatal in childhood as a result of infection or an accelerated lymphoma-like phase. CHS occurs in mink, cattle, and mice, as well as man.|N||
C0007965|A4098843|AT21445733||CSP|form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections; in many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions; transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle.|N||
C0007965|A4098844|AT22523395||MSH|A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle.|N||
C0007987|A4099709|AT21442359||CSP|in vitro (outside the body, tissue, or cell) synthesis of chemical compounds, usually organic, other than drugs; should NOT be used for BIOSYNTHESIS; consider other more specific chemical synthesis terms, such as PEPTIDE CHEMICAL SYNTHESIS or NUCLEIC ACID CHEMICAL SYNTHESIS.|N||
C0007987|A4099710|AT22513578||MSH|Used for the chemical preparation of molecules in vitro. For the formation of chemical substances in organisms, living cells, or subcellular fractions, "biosynthesis" is used.|N||
C0007994|A5830684|AT22534768||MSH|Used for biological phenomena, diseases, syndromes, congenital abnormalities, or symptoms caused by endogenous or exogenous substances.|N||
C0008073|A4243731|AT22533348||MSH|Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)|N||
C0008903|A4145498|AT22520100||MSH|Used for taxonomic or other systematic or hierarchical classification systems.|N||
C0009678|A5840700|AT22516172||MSH|Used with disease headings to indicate those conditions existing at, and usually before, birth. It excludes morphologic abnormalities and birth injuries, for which "abnormalities" and "injuries" are used.|N||
C0010820|A4230320|AT22521563||MSH|Used for cellular appearance of unicellular and multicellular organisms.|N||
C0011644|A2684983|AT18506030||NCI-GLOSS|A chronic disorder marked by hardening and thickening of the skin. Scleroderma can be localized or it can affect the entire body (systemic).|N||
C0011644|A3581562|AT21444594||CSP|chronic hardening and thickening of the skin caused by swelling and thickening of fibrous tissue leading to eventual atrophy of the epidermis; can occur as a localized or a systemic disease.|N||
C0011933|A5850932|AT22535574||MSH|Used with chemical compounds, drugs, and physical agents when these substances are used for studies of clinical function of an organ, or for the diagnosis of human or animal diseases.|N||
C0012160|A4261974|AT22525698||MSH|Used with disease headings for dietary and nutritional management of the disease. The concept does not include vitamin or mineral supplements, for which "drug therapy" may be used.|N||
C0012634|A4271198|AT22526635||MSH|A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.|N||
C0012634|A4295194|AT21443798||CSP|top term heading for all specific disorders and diseases; a disease is a deviation from or interruption of the normal structure or function of any part, organ or system (or combination thereof) of the body that is manifested by a characteristic set of symptoms and signs; a disorder is a derangement or abnormality of function.|N||
C0012634|A7061619|AT60845562||NCI|Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.|N||
C0012634|A8673941|AT63352120||RADLEX|unknown or uncertain etiology, or associated with multiple diseases; for example, pneumonia is a process|N||
C0013217|A4323163|AT22531497||MSH|Used with disease headings for the treatment of disease by the administration of drugs, chemicals, and antibiotics. For diet therapy and radiotherapy, use specific subheadings. Excludes immunotherapy for which "therapy" is used.|N||
C0013557|A4335662|AT22521129||MSH|Used for the economic aspects of any subject, as well as for all aspects of financial management. It includes the raising or providing of funds.|N||
C0013622|A4325177|AT22530721||MSH|Used for education, training programs, and courses in various fields and disciplines, and for training groups of persons.|N||
C0013943|A4346614|AT22514993||MSH|Used with organs, regions, and animal headings for embryologic and fetal development. It is used also with diseases for embryologic factors contributing to postnatal disorders.|N||
C0014442|A2737964|AT18506186||NCI-GLOSS|A protein that speeds up chemical reactions in the body.|N||
C0014442|A2737965|AT18489424||NCI|Molecules that catalyze a chemical reaction. They are usually proteins, although catalytic RNA and DNA molecules have been identified.|N||
C0014442|A4372568|AT21441788||CSP|protein molecules that possess catalytic activity; they may occur naturally or be synthetically created; for catalytic RNA use RIBOZYME.|N||
C0014442|A4439196|AT22521054||MSH|Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified.|N||
C0014445|A5677443|AT22524174||MSH|Used with organisms, except vertebrates, and with organs and tissues. It is also used with diseases for enzymes during the course of the disease, but excludes diagnostic enzyme tests, for which "diagnosis" is used.|N||
C0014508|A4441418|AT22529929||MSH|Used with human and veterinary diseases for the distribution of disease, factors which cause disease, and the attributes of disease in defined populations; includes incidence, frequency, prevalence, endemic and epidemic outbreaks; also surveys and estimates of morbidity in geographic areas and in specified populations. Used also with geographical headings for the location of epidemiologic aspects of a disease. Excludes mortality for which "mortality" is used.|N||
C0014894|A2451482|AT49914946||SPN|Dye and chemical solution stains for medical purposes are mixtures of synthetic or natural dyes or nondye chemicals in solutions used in staining cells and tissues for diagnostic histopathology, cytopathology, or hematology.|N||
C0014894|A2739548|AT18340267||NCI|Encoded by Esterase Genes, Esterases catalyze hydrolysis of ester bonds to produce alcohol and acid reaction products. (NCI)|N||
C0014894|A4454562|AT21442540||CSP|any of various enzymes that catalyze the hydrolysis of an ester to produce an alcohol and an acid.|N||
C0015033|A4383401|AT22536288||MSH|Used with diseases for ethnic, cultural, or anthropological aspects, and with geographic headings to indicate the place of origin of a group of people.|N||
C0015127|A4462295|AT22527312||MSH|Used with diseases for causative agents including microorganisms and includes environmental and social factors and personal habits as contributing factors. It includes pathogenesis.|N||
C0016755|A4525583|AT22517809||MSH|An enzyme that catalyzes the conversion of D-fructose 1,6-bisphosphate and water to D-fructose 6-phosphate and orthophosphate. EC 3.1.3.11.|N||
C0017399|A4442969|AT22526116||MSH|Used for mechanisms of heredity and the genetics of organisms, for the genetic basis of normal and pathologic states, and for the genetic aspects of endogenous chemicals. It includes biochemical and molecular influence on genetic material.|N||
C0017755|A2823555|AT22513607||MSH|An enzyme that catalyzes the conversion of D-glucose 6-phosphate and water to D-glucose and orthophosphate. EC 3.1.3.9.|N||
C0017881|A2827916|AT21445617||CSP|first step in the phosphatidic acid synthesis pathway.|N||
C0017881|A2827992|AT22532297||MSH|Any salt or ester of glycerophosphoric acid.|N||
C0018939|A2863999|AT22522858||MSH|Disorders of the blood and blood forming tissues.|N||
C0018939|A3995826|AT21449899||CSP|condition in which there is a deviation from or interruption of the normal structure or function of the blood and blood forming tissues.|N||
C0018981|A2874701|AT22519712||MSH|Hematologic diseases and diseases of the lymphatic system collectively. Hemic diseases include disorders involving the formed elements (e.g., ERYTHROCYTE AGGREGATION, INTRAVASCULAR) and chemical components (e.g., BLOOD PROTEIN DISORDERS); lymphatic diseases include disorders relating to lymph, lymph nodes, and lymphocytes.|N||
C0019247|A2745858|AT18330879||NCI|Genetic Diseases are diseases in which inherited genes predispose to increased risk. The genetic disorders associated with cancer often result from an alteration or mutation in a single gene. The diseases range from rare dominant cancer family syndrome to familial tendencies in which low-penetrance genes may interact with other genes or environmental factors to induce cancer. Research may involve clinical, epidemiologic, and laboratory studies of persons, families, and populations at high risk of these disorders.|N||
C0019247|A2874352|AT22533379||MSH|Diseases caused by genetic mutations that are inherited from a parent's genome.|N||
C0019247|A4442735|AT51062154||CSP|general term for any disorder caused by a genetic mechanism, comprising chromosome aberrations or anomalies, mendelian or monogenic or single-gene disorders, and multifactorial disorders; note that all genetic disorders are not treed under this term; see RTs for others; in addition, many disorders not treed here or under RTs may have a genetic component.|N||
C0019665|A2893625|AT22513651||MSH|Used for the historical aspects of any subject. It includes brief historical notes but excludes case histories.|N||
C0020289|A2639673|AT18328375||NCI|Enzymes (EC class 3) cleaving substrates with addition of H2O at the point of cleavage; e.g., esterases, phosphatases, nucleases, peptidases. SYN hydrolyzing enzymes.|N||
C0020289|A2909277|AT22526185||MSH|Any member of the class of enzymes that catalyze the cleavage of the substrate and the addition of water to the resulting molecules, e.g., ESTERASES, glycosidases (GLYCOSIDE HYDROLASES), lipases, NUCLEOTIDASES, peptidases (PEPTIDE HYDROLASES), and phosphatases (PHOSPHORIC MONOESTER HYDROLASES). EC 3.|N||
C0020291|A2639677|AT18506872||NCI-GLOSS|A chemical reaction that uses water to break down a compound.|N||
C0020291|A2639678|AT18488866||NCI|A chemical reaction in which a water molecule is added to a compound. This addition often involves the splitting or cleavage of the molecule. The hydroxyl group is incorporated into one fragment of the compound and the hydrogen atom in the other.|N||
C0020291|A2909369|AT21443667||CSP|process of cleaving a chemical compound by the addition of a molecule of water.|N||
C0020291|A2909370|AT22519384||MSH|The process of cleaving a chemical compound by the addition of a molecule of water.|N||
C0021051|A2641513|AT18505666||NCI-GLOSS|The inability of the body to produce an immune response.|N||
C0021051|A2641513|AT18507077||NCI-GLOSS|The decreased ability of the body to fight infection and disease.|N||
C0021051|A2641523|AT18341733||NCI|Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.|N||
C0021051|A2810156|AT43086925||FDA|A deficiency of immune response or a disorder characterized by deficient immune response.|N||
C0021051|A2940833|AT21442350||CSP|deficiency of immune response or a disorder characterized by deficient immune response; classified as antibody (B cell), cellular (T cell), or combined immunodeficiency, or phagocytic dysfunction disorders.|N||
C0021051|A2942550|AT22535570||MSH|Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.|N||
C0021053|A0184505|AT16135202||CTEP|CTEP_For_FDA: 90600092/Immune disorder|N||
C0021053|A2641465|AT18341084||NCI|A disorder resulting from an abnormality in the immune system. -- 2003|N||
C0021053|A2930700|AT22513983||MSH|Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.|N||
C0021053|A6872927|AT52061743||CDISC|A disorder resulting from an abnormality in the immune system. -- 2003 (NCI)|N||
C0021632|A2969662|AT22522363||MSH|Used with diagnostic or therapeutic procedures, analytic techniques, and specialties or disciplines, for the development or modification of apparatus, instruments, or equipment.|N||
C0022709|A3354354|AT21449210||CSP|Cl- dependent, zinc glycoprotein that is generally membrane bound.|N||
C0022709|A3354357|AT22514498||MSH|A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, -Xaa-*-Xbb-Xcc, when neither Xaa nor Xbb is Pro. It is a Cl(-)-dependent, zinc glycoprotein that is generally membrane-bound and active at neutral pH. It may also have endopeptidase activity on some substrates. (From Enzyme Nomenclature, 1992) EC 3.4.15.1.|N||
C0023242|A5701221|AT22529873||MSH|Used for laws, statutes, ordinances, or government regulations, as well as for legal controversy and court decisions.|N||
C0023510|A3038919|AT21449357||CSP|disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.|N||
C0023510|A3038920|AT22513458||MSH|Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.|N||
C0023779|A2648157|AT56566676||NCI|A class of hydrocarbon-containing organic compounds. Lipids are insoluble in water but soluble in nonpolar solvents and play important roles in living organisms: these roles include functioning as energy storage molecules, serving as structural components of cell membranes, and constituting important signaling molecules. Lipids can be subdivided into 2 groups: fatty acids and glycerides.|N||
C0023779|A3052319|AT21448520||CSP|any of a class of hydrophobic biochemicals including fats, long- chain fatty acids, steroids, oils, and waxes.|N||
C0023779|A3052462|AT22526413||MSH|A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)|N||
C0023820|A2648319|AT43122151||NCI|An important class of serum proteins in which a spherical hydrophobic core of triglycerides or cholesterol esters surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins. Classified according to density: chylomicrons, large low density particles, very low density, low density and high density species. Important in lipid transport, especially cholesterol transport in the blood stream. Abnormalities in lipoprotein metabolism have been implicated in certain heart diseases.|N||
C0023820|A3053320|AT55404354||MSH|Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. The large lipoproteins (CHYLOMICRONS; VLDL) are to transport triglycerides, and the small lipoproteins (LDL; HDL) are to transport cholesterol.|N||
C0024752|A3096436|AT22531820||MSH|Used with disciplines and programs for the demand, supply, distribution, recruitment, and use of personnel.|N||
C0025141|A3111267|AT22520183||MSH|The premier bibliographic database of the NATIONAL LIBRARY OF MEDICINE. MEDLINE® (MEDLARS Online) is the primary subset of PUBMED and can be searched on NLM's Web site in PubMed or the NLM Gateway. MEDLINE references are indexed with MEDICAL SUBJECT HEADINGS (MeSH).|N||
C0025249|A3113097|AT21445351||CSP|lipids, predominantly phospholipids, cholesterol and small amounts of glycolipids in cellular and intracellular membranes; these lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside; required for active transport, several enzymatic activities and membrane formation.|N||
C0025249|A3114889|AT22524697||MSH|Lipids, predominantly phospholipids, cholesterol and small amounts of glycolipids found in membranes including cellular and intracellular membranes. These lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside. Membrane lipids are required for active transport, several enzymatic activities and membrane formation.|N||
C0025250|A2655035|AT18332367||NCI|A cell-surface enzyme found on prostate epithelial cells. It can inhibit cell migration of prostate cancer cells, probably by disrupting focal adhesion kinase phosphorylation. (from J Clin Invest 2000;106:1399-1407 via Medscape)|N||
C0025250|A2655035|AT18335691||NCI|Abundant in the kidney proximal tubule brush border and glomerular epithelium, but expressed in a variety of tissues by human MME Gene (M13 Peptidase Family), 749-aa 100-kDa Membrane Metalloendopeptidase is a zinc-binding type II transmembrane glycoprotein that preferentially cleaves Gly-Phe bonds of peptides at the N side of hydrophobic residues and inactivates several peptide hormones, including insulin, glucagon, enkephalins, substance P, neurotensin, oxytocin, and bradykinin, as well as casein, hemoglobin, and other proteins and polypeptides. An important cell surface marker of human acute lymphocytic leukemia, MME is present on pre-B leukemic cells, which represent 85% of cases of ALL. (NCI)|N||
C0025250|A3208775|AT22530157||MSH|Enzyme that is a major constituent of kidney brush-border membranes and is also present to a lesser degree in the brain and other tissues. It preferentially catalyzes cleavage at the amino group of hydrophobic residues of the B-chain of insulin as well as opioid peptides and other biologically active peptides. The enzyme is inhibited primarily by EDTA, phosphoramidon, and thiorphan and is reactivated by zinc. Neprilysin is identical to common acute lymphoblastic leukemia antigen (CALLA Antigen), an important marker in the diagnosis of human acute lymphocytic leukemia. There is no relationship with CALLA PLANT.|N||
C0025517|A2655577|AT18506169||NCI-GLOSS|A condition in which normal metabolic processes are disrupted, usually because of a missing enzyme.|N||
C0025517|A2655578|AT18334048||NCI|A congenital (due to inherited enzyme abnormality) or acquired (due to failure of a metabolic important organ) disorder resulting from an abnormal metabolic process. -- 2003|N||
C0025517|A3121170|AT22513901||MSH|Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)|N||
C0025517|A3121327|AT21447558||CSP|condition in which there is a deviation from or caused by an abnormal metabolic process; can be congenital due to inherited enzyme abnormality (INBORN METABOLISM DISORDER) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver.|N||
C0025520|A3123411|AT22521627||MSH|Used with organs, cells and subcellular fractions, organisms, and diseases for biochemical changes and metabolism. It is used also with drugs and chemicals for catabolic changes (breakdown of complex molecules into simpler ones). For anabolic processes (conversion of small molecules into large), BIOSYNTHESIS is used. For enzymology, pharmacokinetics, and secretion use the specific subheadings.|N||
C0025521|A2945533|AT21445464||CSP|errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.|N||
C0025521|A3123416|AT22531614||MSH|Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.|N||
C0025664|A5706927|AT22528202||MSH|Used with techniques, procedures, and programs for methods.|N||
C0025953|A3140617|AT22524041||MSH|Used with organs, animals, and higher plants and with diseases for microbiologic studies. For parasites, "parasitology" is used; for viruses, "virology" is used.|N||
C0026566|A3159579|AT22517451||MSH|Used with human and veterinary diseases for mortality statistics. For deaths resulting from various procedures statistically but for a death resulting in a specific case, use FATAL OUTCOME, not /mortality.|N||
C0028625|A3254879|AT22521317||MSH|A class of enzymes that catalyze the conversion of a nucleotide and water to a nucleoside and orthophosphate. EC 3.1.3.-.|N||
C0028678|A3249362|AT22524078||MSH|Used with diseases for nursing care and techniques in their management. It includes the nursing role in diagnostic, therapeutic, and preventive procedures.|N||
C0029236|A5729334|AT22522099||MSH|Used for administrative structure and management.|N||
C0030657|A5734007|AT22523492||MSH|Used with microorganisms, viruses, and parasites for studies of their ability to cause disease in man, animals, or plants.|N||
C0030660|A2671436|AT18336916||NCI|A biologic function or a process having an abnormal or deleterious effect at the subcellular, cellular, multicellular, or organismal level. (NCI)|N||
C0030660|A3340336|AT21442771||CSP|abnormal mechanisms and forms involved in the dysfunctions of tissues and organs.|N||
C0030660|A3342539|AT22529170||MSH|The abnormal mechanisms and forms involved in the dysfunctions of tissues and organs.|N||
C0031306|A3366738|AT22519651||MSH|Disorders in which phagocytic cells cannot kill ingested bacteria; characterized by frequent recurring infection with formulation of granulomas.|N||
C0031306|A3366744|AT21445212||CSP|disorders in which phagocytic cells cannot kill ingested bacteria; characterized by frequent recurring infection with formulation of granulomas.|N||
C0031328|A3367264|AT22517341||MSH|Used for the mechanism, dynamics and kinetics of exogenous chemical and drug absorption, biotransformation, distribution, release, transport, uptake and elimination as a function of dosage, extent and rate of metabolic processes.|N||
C0031607|A3377963|AT22514829||MSH|A phosphomonoesterase involved in the synthesis of triacylglycerols. It catalyzes the hydrolysis of phosphatidates with the formation of diacylglycerols and orthophosphate. EC 3.1.3.4.|N||
C0031612|A3380809|AT22525495||MSH|Fatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups.|N||
C0031617|A3380836|AT21444242||CSP|derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a choline moiety.|N||
C0031617|A8688035|AT60880058||MSH|A complex mixture of PHOSPHOLIPIDS; GLYCOLIPIDS; and TRIGLYCERIDES; with substantial amounts of PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; and PHOSPHATIDYLINOSITOLS, which are sometimes loosely termed as 1,2-diacyl-3-phosphocholines. Lecithin is a component of the CELL MEMBRANE and commercially extracted from SOYBEANS and EGG YOLK. The emulsifying and surfactant properties are useful in FOOD ADDITIVES and for forming organogels (GELS).|N||
C0031676|A3379577|AT21446788||CSP|any lipid that contains phosphorus, including those with a glycerol backbone or a backbone of sphingosine or related substance; these polar lipids are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids.|N||
C0031676|A3382541|AT22530225||MSH|Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system.|N||
C0031678|A2673466|AT63369297||NCI|A class of enzymes that catalyze the removal of phosphate groups from their substrates.|N||
C0031678|A3379718|AT21442854||CSP|a group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate.|N||
C0031678|A3383233|AT22516150||MSH|A group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate. EC 3.1.3.|N||
C0031686|A2673573|AT18334918||NCI|Encoded by Protein Phosphatase Genes, Protein Phosphatase enzymes remove tyrosine-, serine-, or threonine-bound phosphate groups from many phosphoproteins, including enzymes phosphorylated by a tyrosine kinase or a serine/threonine kinase. (NCI)|N||
C0031686|A3379989|AT21448678||CSP|family of enzymes which dephosphorylate other proteins, thus reversing the action of protein kinases in posttranslational regulation of protein function.|N||
C0031686|A8688877|AT60880464||MSH|A group of enzymes removing the SERINE- or THREONINE-bound phosphate groups from a wide range of phosphoproteins, including a number of enzymes which have been phosphorylated under the action of a kinase. (Enzyme Nomenclature, 1992)|N||
C0031714|A3383565|AT22530615||MSH|An enzyme that deactivates glycogen phosphorylase a by releasing inorganic phosphate and phosphorylase b, the inactive form. EC 3.1.3.17.|N||
C0031843|A3383993|AT22514239||MSH|Used with organs, tissues, and cells of unicellular and multicellular organisms for normal function. It is used also with biochemical substances, endogenously produced, for their physiologic role.|N||
C0031847|A5739487|AT22513576||MSH|Used with organs and diseases for disordered function in disease states.|N||
C0032191|A3400414|AT22531571||MSH|Platelet membrane glycoprotein IIb is an integrin alpha subunit that heterodimerizes with INTEGRIN BETA3 to form PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX. It is synthesized as a single polypeptide chain which is then postranslationally cleaved and processed into two disulfide-linked subunits of approximately 18 and 110 kDa in size.|N||
C0032191|A8896721|AT63361708||NCI|Integrin alpha-IIb (1039 aa, ~113 kDa) is encoded by the human ITGA2B gene. This protein is involved in the mediation of platelet clotting.|N||
C0032197|A3397723|AT22521648||MSH|Disorder characterized by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5HT are normally stored.|N||
C0032344|A3408499|AT22530757||MSH|Used with drugs, chemicals, and industrial materials for human or animal poisoning, acute or chronic, whether the poisoning is accidental, occupational, suicidal, by medication error, or by environmental exposure.|N||
C0033107|A5747523|AT22532138||MSH|Used with disease headings for increasing human or animal resistance against disease (e.g., immunization), for control of transmission agents, for prevention and control of environmental hazards, or for prevention and control of social factors leading to disease. It includes preventive measures in individual cases.|N||
C0033684|A2677552|AT18504522||NCI|A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.|N||
C0033684|A3455108|AT21443485||CSP|linear polymers of alpha-L-aminoacids ranging in size from a few thousand to over 1 million daltons, capable of oligomerization, with specific functions dictated by aminoacid sequence and encoded genetically.|N||
C0033684|A3456543|AT22519846||MSH|Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.|N||
C0033684|A7061903|AT52063965||MGED|Polymer of amino acids.|N||
C0034085|A1029480|AT49954398||UWDA|Secretion produced by Type 2 pulmonary alveolar cell.|N||
C0034085|A2649635|AT18326058||NCI|Pulmonary surfactant lines the lung epithelium and lowers surface tension to prevent collapse at end-expiration. Deficiency of pulmonary surfactant results in respiratory distress syndrome (RDS) in premature infants. Lung surfactant is synthesized in alveolar type II cells, stored in lamellar bodies and secreted via exocytosis.|N||
C0034085|A3468168|AT21444208||CSP|phospholipids secreted by the great alveolar cells into alveoli and respiratory air passages which contributes to the elastic property of pulmonary tissue.|N||
C0034085|A3468170|AT22529567||MSH|Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI.|N||
C0034085|A8899555|AT63369040||CDISC|Pulmonary surfactant lines the lung epithelium and lowers surface tension to prevent collapse at end-expiration. Deficiency of pulmonary surfactant results in respiratory distress syndrome (RDS) in premature infants. Lung surfactant is synthesized in alveolar type II cells, stored in lamellar bodies and secreted via exocytosis. (NCI)|N||
C0034526|A5862223|AT22530739||MSH|Used for effects of ionizing and nonionizing radiation upon living organisms, organs and tissues, and their constituents, and upon physiologic processes. It includes the effect of irradiation on drugs and chemicals.|N||
C0034571|A3482292|AT22517940||MSH|Used with organs, regions, and diseases for x-ray examinations. It does not include radionuclide imaging for which "radionuclide imaging" is used.|N||
C0034607|A3496048|AT22530116||MSH|Used for radionuclide imaging of any anatomical structure, or for the diagnosis of disease.|N||
C0034619|A3496445|AT22518312||MSH|Used with disease headings for the therapeutic use of ionizing and nonionizing radiation. It includes the use of radioisotope therapy.|N||
C0034992|A3515158|AT22520171||MSH|Used with diseases and surgical procedures for restoration of function of the individual.|N||
C0036536|A2721292|AT18326655||NCI|Production by a cell or aggregation of cells (a gland) of a physiologically active substance and its movement out of the cell or organ in which it is formed. Discharge across the cell membrane, into the intracellular space or ducts, of endogenous substances resulting from the activity of intact cells of glands, tissues, or organs.|N||
C0036536|A3575252|AT22535079||MSH|Used for the discharge across the cell membrane, into the extracellular space or ducts, of endogenous substances resulting from the activity of intact cells of glands, tissues, or organs.|N||
C0036536|A3589414|AT21448257||CSP|production of a hormone or other substance which will perform a specialized function outside the gland, cell or organ.|N||
C0036775|A3586555|AT22529069||MSH|Normal human serum albumin mildly iodinated with radioactive iodine (131-I) which has a half-life of 8 days, and emits beta and gamma rays. It is used as a diagnostic aid in blood volume determination. (from Merck Index, 11th ed)|N||
C0037088|A2742744|AT50055949||NCI|Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom).|N||
C0037088|A3597242|AT22536913||MSH|Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.|N||
C0037088|A3597247|AT21442777||CSP|clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.|N||
C0037274|A2686757|AT50092062||NCI|Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.|N||
C0037274|A3612033|AT21444024||CSP|impairment of health or a condition of abnormal functioning of the skin.|N||
C0037274|A6871726|AT52061626||CDISC|Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs. (NCI)|N||
C0038137|A5776351|AT22523536||MSH|Used with facilities, personnel, and program headings for the development, testing, and application of standards of adequacy or acceptable performance and with chemicals and drugs for standards of identification, quality, and potency. It includes health or safety standards in industries and occupations.|N||
C0038209|A5776586|AT22517925||MSH|Used with non-disease headings for the expression of numerical values which describe particular sets or groups of data. It excludes manpower distribution for which "manpower" is used and excludes supply or demand for which "supply & distribution" is used.|N||
C0038849|A5780224|AT22532201||MSH|Used for the quantitative availability and distribution of material, equipment, health services, personnel, and facilities. It excludes food supply and water supply in industries and occupations.|N||
C0038895|A3699362|AT22530466||MSH|Used for operative procedures on organs, regions, or tissues in the treatment of diseases, including tissue section by lasers. It excludes transplantation, for which "transplantation" is used.|N||
C0039082|A2694740|AT18506326||NCI-GLOSS|(SIN-drome) A set of symptoms or conditions that occur together and suggest the presence of a certain disease or an increased chance of developing the disease.|N||
C0039082|A3705893|AT21446607||CSP|heading term for a set of symptoms, usually three or more, which have a complex etiology and characterize a particular pathological state.|N||
C0039082|A3712873|AT22523694||MSH|A symptom complex of unknown etiology, that is characteristic of a particular abnormality.|N||
C0039798|A3736925|AT22524628||MSH|Used with diseases for therapeutic interventions except drug therapy, diet therapy, radiotherapy, and surgery, for which specific subheadings exist. The concept is also used for articles and books dealing with multiple therapies.|N||
C0040539|A3763545|AT22526089||MSH|Used with drugs and chemicals for experimental human and animal studies of their ill effects. It includes studies to determine the margin of safety or the reactions accompanying administration at various dose levels. It is used also for exposure to environmental agents. Poisoning should be considered for life-threatening exposure to environmental agents.|N||
C0040722|A5788142|AT22529973||MSH|Used with diseases for studies of the modes of transmission.|N||
C0040733|A3768215|AT22532994||MSH|Used with organs, tissues, or cells for transplantation from one site to another within the same subject, or from one subject to another of the same species or different species.|N||
C0040833|A5788561|AT22534695||MSH|Used for the manner in which a subject changes, qualitatively or quantitatively, with time, whether past, present, or future. It excludes discussions of the course of disease in particular patients.|N||
C0041623|A5792238|AT22519466||MSH|Used with tissues and cells (including neoplasms) and microorganisms for microanatomic structures, generally below the size visible by light microscopy.|N||
C0042037|A3832734|AT22535621||MSH|Used for the presence or analysis of substances in the urine, and also for the examination of, or changes in, the urine in disease.|N||
C0042153|A5794329|AT22536220||MSH|Used with equipment, facilities, programs, services, and health personnel for discussions, usually with data, of how much they are used. It includes discussions of overuse and underuse.|N||
C0042614|A5796137|AT22533979||MSH|Used for naturally occurring diseases in animals, or for diagnostic, preventive, or therapeutic procedures used in veterinary medicine.|N||
C0054450|A2716583|AT18322911||NCI|Ubiquitous heterodimeric human Calcineurin is Ca(2+)/calmodulin-regulated protein phosphatase involved in many biologic activities as a modifier of phosphorylation status. Composed of widely expressed or tissue-restricted 55-60-kDa calmodulin-binding catalytic subunit (PPP Phosphatase/PP-2B Family) and conserved 19-kD Ca(2+)-sensitive regulatory subunit, Calcineurin appears to regulate glycolytic metabolism, nuclear translocation of NFATC1 transcription factor, sperm motility, and dopaminergic signal transduction and NMDA receptor-dependent synaptic plasticity. (NCI)|N||
C0054450|A4040852|AT21443187||CSP|nonEC; calcium-calmodulin dependent protein phosphatase found in nerve cells and involved in intracellular signal transduction between the calcium and protein phosphorylation pathways.|N||
C0054450|A4040855|AT22514640||MSH|A calcium- and calmodulin-binding protein present in highest concentrations in the central nervous system. Calcineurin is composed of two subunits. A catalytic subunit, calcineurin A, and a regulatory subunit, calcineurin B, with molecular weights of about 60 kDa and 19 kDa, respectively. Calcineurin has been shown to dephosphorylate a number of phosphoproteins including histones, myosin light chain, and the regulatory subunit of cAMP-dependent protein kinase. It is involved in the regulation of signal transduction and is the target of an important class of immunophilin-immunosuppressive drug complexes in T-lymphocytes that act by inhibiting T-cell activation.|N||
C0054941|A3864098|AT22514741||MSH|Glycoproteins expressed on cortical thymocytes and on some dendritic cells and B-cells. Their structure is similar to that of MHC Class I and their function has been postulated as similar also. CD1 antigens are highly specific markers for human LANGERHANS CELLS.|N||
C0054941|A4083900|AT21448924||CSP|antigen presenting molecule encoded outside of the major histocompatibility complex.|N||
C0054942|A3863961|AT22524452||MSH|A group of three different alpha chains (CD11a, CD11b, CD11c) that are associated with an invariant CD18 beta chain (ANTIGENS, CD18). The three resulting leukocyte-adhesion molecules (RECEPTORS, LEUKOCYTE ADHESION) are LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGE-1 ANTIGEN; and ANTIGEN, P150,95.|N||
C0054943|A3863984|AT22530239||MSH|Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide.|N||
C0054946|A2719837|AT18333766||NCI|Expressed during B-cell ontogeny (early pre-B-cell to plasma cell) by human CD20 Gene (MS4A Family), 297-aa 33-kDa CD20 Antigen is a phosphorylated cell surface integral membrane protein shown to participate in B-cell proliferation, development, and differentiation into plasma cells. MS4A family proteins share structural similarity, sequence homology, and unique expression patterns among hematopoietic cells and nonlymphoid tissues. MS4A proteins contain 4 highly conserved transmembrane domains, flanked by N- and C-terminal cytoplasmic regions. CD20 may be involved in regulation of B-cell activation and may be regulated by protein kinases. (NCI)|N||
C0054946|A3871635|AT22528269||MSH|Unglycosylated phosphoproteins expressed only on B-cells. They are regulators of transmembrane Ca2+ conductance and thought to play a role in B-cell activation and proliferation.|N||
C0054947|A4075925|AT21446218||CSP|B cell specific adhesion molecule; active in adhesion to monocytes and T cells.|N||
C0054947|A5804736|AT22515030||MSH|A lectin and cell adhesion molecule found in B-LYMPHOCYTES. It interacts with SIALIC ACIDS and mediates signaling from B-CELL ANTIGEN RECEPTORS.|N||
C0054947|A8685367|AT60864565||NCI|B-cell receptor CD22 (847 aa, 95 kD) is a cell adhesion process protein that is encoded by the human CD22 gene and may have a role in cell adhesion.|N||
C0054948|A5805733|AT22518242||MSH|A cell adhesion protein that was originally identified as a heat stable antigen in mice. It is involved in METASTASIS and is highly expressed in many NEOPLASMS.|N||
C0054949|A3864192|AT55404763||MSH|A member of the tumor necrosis factor receptor superfamily found on most T-LYMPHOCYTES. Activation of the receptor by CD70 ANTIGEN results in the increased proliferation of CD4-POSITIVE T-LYMPHOCYTES and CD8-POSITIVE T-LYMPHOCYTES. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.|N||
C0054950|A2698227|AT18329768||NCI|Expressed in activated T- and B-cells by human TNFRSF8 Gene (TNFR Superfamily) as distinct serine and tyrosine phosphorylated Long (595-aa, 64-kDa precursor type I membrane protein) and Short (cytoplasmic) isoforms, TNF Receptor 8 contains 6 TNFR-Cys repeats. A positive regulator of apoptosis and receptor for TNFSF8/CD30L, TNFRSF8 interacts with the TRAF1, TRAF2, TRAF3, and TRAF5 mediators of signal transduction and regulates gene expression through NF-Kappa-B activation. A Hodgkin's disease associated antigen, TNFRSF8 limits the proliferative potential of autoreactive CD8 effector T cells and protects against autoimmunity. (NCI)|N||
C0054950|A3864203|AT55404106||MSH|A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. They are found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; NEUTROPHILS; EOSINOPHILS; MAST CELLS and NK CELLS. Overexpression of CD30 antigen in hematopoietic malignancies make the antigen clinically useful as a biological tumor marker. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.|N||
C0054953|A3864218|AT22517269||MSH|Glycoproteins found on immature hematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood system is restricted to a small number of progenitor cells in the bone marrow.|N||
C0054953|A4076203|AT21443855||CSP|surface glycophosphoprotein that is expressed on hematopoietic stem cells but not on mature blood cells.|N||
C0054953|A8684997|AT60864477||NCI|Hematopoietic progenitor cell antigen CD34 (385 aa, 41 kD) is a cell motility process protein that is encoded by the human CD34 gene and has a role in cell-cell adhesion and may have a role in leukocyte migration.|N||
C0054954|A3871774|AT22536291||MSH|Leukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.|N||
C0054954|A8686473|AT60873799||NCI|Platelet glycoprotein 4 (472 aa, 53 kD) is a cell adhesion process protein that is encoded by the human CD36 gene and has roles in blood coagulation and cell adhesion.|N||
C0054959|A2700432|AT60864046||NCI|Tumor necrosis factor receptor superfamily member 5 (277 aa, 31 kD) is a cell fate protein that is encoded by the human CD40 gene and has roles in inflammatory response, B-cell proliferation and apoptosis.|N||
C0054959|A2700432|AT63373113||NCI|Related to NGFR, TNFR-alpha, and CD27, CD40 is a 50 kD glycophosphoprotein homodimer expressed on mature B-cells, but not on plasma cells, that plays an important role in B-cell development and activation. These CD40 homologies imply that its ligand may be a soluble factor and that CD40 is a member of the cytokine receptor family. CD40/CD40-ligand interactions play a critical role in the activation of humoral and cell-mediated immune responses. CD40-dependent activation of B-cells is important for generation of memory B-cells within germinal centers. (OMIM and NCI)|N||
C0054959|A3871777|AT55404663||MSH|A member of the tumor necrosis factor receptor superfamily with specificity for CD40 LIGAND. It is found on mature B-LYMPHOCYTES and some EPITHELIAL CELLS, lymphoid DENDRITIC CELLS. Evidence suggests that CD40-dependent activation of B-cells is important for generation of memory B-cells within the germinal centers. Mutations of the gene for CD40 antigen result in HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 3. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.|N||
C0054959|A4076447|AT21444014||CSP|50 kD glycoprotein expressed on all B cells; plays an important role in B cell development and activation.|N||
C0054961|A2677735|AT18323787||NCI|This protein is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus belongs to receptor type PTP. It is specifically expressed in hematopoietic cells. It has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. It also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling. (RefSeq)|N||
C0054961|A3864333|AT60879504||MSH|High-molecular weight glycoproteins uniquely expressed on the surface of LEUKOCYTES and their hemopoietic progenitors. They contain a cytoplasmic protein tyrosine phosphatase activity which plays a role in intracellular signaling from the CELL SURFACE RECEPTORS. The CD45 antigens occur as multiple isoforms that result from alternative mRNA splicing and differential usage of three exons.|N||
C0054964|A3872041|AT22527568||MSH|Glycoproteins expressed on all mature T-cells, thymocytes, and a subset of mature B-cells. Antibodies specific for CD5 can enhance T-cell receptor-mediated T-cell activation. The B-cell-specific molecule CD72 is a natural ligand for CD5. (From Abbas et al., Cellular and Molecular Immunology, 2d ed, p156)|N||
C0054964|A4084890|AT21446139||CSP|lymphocyte marker expressed on T and the Ly-1 subset of B cells; sends accessory signals necessary for CD3-mediated T cell activation, possibly via phosphorylation of inositol phosphate; Ly-1 B cells have a propensity for autoantibody production.|N||
C0054964|A8676500|AT60851301||NCI|T-cell surface glycoprotein CD5 (495 aa, ~54 kDa) is encoded by the human CD5 gene. This protein may be involved in regulating the proliferation of T-cells.|N||
C0054965|A3864494|AT22516096||MSH|Oligosaccharide antigenic determinants found principally on NK cells and T-cells. Their role in the immune response is poorly understood.|N||
C0054966|A3864506|AT22526573||MSH|Small glycoproteins found on both hematopoietic and non-hematopoietic cells. CD59 restricts the cytolytic activity of homologous complement by binding to C8 and C9 and blocking the assembly of the membrane attack complex. (From Barclay et al., The Leukocyte Antigen FactsBook, 1993, p234)|N||
C0054968|A2695689|AT18324549||NCI|Expressed in thymocytes and mature T cells by human CD7 Gene (Immunoglobulin Superfamily), 240-aa 25-kDa (precursor) T-Cell Antigen CD7 is a cell surface type I transmembrane glycoprotein that interacts with SECTM1, contains an Ig-like domain, and is essential in T-cell interactions and in T-cell/B-cell interaction during early lymphoid development. One of the earliest antigens on cells of the T-lymphocyte lineage, CD7 is the most reliable clinical marker of T-cell acute lymphocytic leukemia. (NCI)|N||
C0054968|A3872151|AT22516011||MSH|Differentiation antigens expressed on pluripotential hematopoietic cells, most human thymocytes, and a major subset of peripheral blood T-lymphocytes. They have been implicated in integrin-mediated cellular adhesion and as signalling receptors on T-cells.|N||
C0056182|A3504457|AT22528032||MSH|Molecular sites on or in some B-lymphocytes and macrophages that recognize and combine with COMPLEMENT C3B. The primary structure of these receptors reveal that they contain transmembrane and cytoplasmic domains, with their extracellular portion composed entirely of thirty short consensus repeats each having 60 to 70 amino acids.|N||
C0056184|A3490675|AT22530273||MSH|Molecular sites on or in B-lymphocytes, follicular dendritic cells, lymphoid cells, and epithelial cells that recognize and combine with COMPLEMENT C3D. Human complement receptor 2 (CR2) serves as a receptor for both C3dg and the gp350/220 glycoprotein of HERPESVIRUS 4, HUMAN, and binds the monoclonal antibody OKB7, which blocks binding of both ligands to the receptor.|N||
C0056196|A3503174|AT22527142||MSH|A G-protein-coupled receptor that signals an increase in intracellular calcium in response to the potent ANAPHYLATOXIN peptide COMPLEMENT C5A.|N||
C0063695|A2642825|AT18327800||NCI|LFA-1 is a receptor for ICAM1, a surface molecule constitutively expressed on some tissues and induced on others in inflammation. The interaction of LFA-1 with ICAM provides essential accessory adhesion signals in many immune interactions, including those between T- and B-lymphocytes and cytotoxic T-cells and their targets.|N||
C0063695|A2642825|AT18336902||NCI|Similar to NCAM, ICAM-1 is a ligand for LFA antigens with a role in leukocyte adhesion and inflammation. Its production in a variety of cells is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue. ICAM-1 protein is the major human rhinovirus receptor. (from OMIM 147840 and NCI)|N||
C0063695|A2965610|AT22529442||MSH|A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue.|N||
C0064830|A2642770|AT60864330||NCI|Integrin beta-2 (769 aa, 85 kD) is a cell motility process protein that is encoded by the human ITGB2 gene and has roles in leukocyte adhesion and neutrophil chemotaxis.|N||
C0064830|A3864091|AT22524861||MSH|Cell-surface glycoprotein beta-chains that are non-covalently linked to specific alpha-chains of the CD11 family of leukocyte-adhesion molecules (RECEPTORS, LEUKOCYTE-ADHESION). A defect in the gene encoding CD18 causes LEUKOCYTE-ADHESION DEFICIENCY SYNDROME.|N||
C0072470|A2692966|AT18325738||NCI|Encodes mast cell growth factor, a tyrosine protein kinase. Also known as SCF Receptor and CD117. Can be activated to become an oncogene. (See Oncogene, KIT)|N||
C0072470|A2692966|AT18328556||NCI|Cell surface receptor for Stem Cell Factor. Product of the KIT gene.|N||
C0072470|A2724793|AT18506790||NCI-GLOSS|A protein on the surface of some cells that binds to stem cell factor (a substance that causes certain types of cells to grow). Altered forms of this receptor may be associated with some types of cancer.|N||
C0072470|A3460960|AT22522468||MSH|A protein-tyrosine kinase receptor that is specific for STEM CELL FACTOR. This interaction is crucial for the development of hematopoietic, gonadal, and pigment stem cells. Genetic mutations that disrupt the expression of PROTO-ONCOGENE PROTEINS C-KIT are associated with PIEBALDISM, while overexpression or constitutive activation of the c-kit protein-tyrosine kinase is associated with tumorigenesis.|N||
C0074479|A4084488|AT21445967||CSP|integral membrane sialoglycoprotein expressed on the surface of virtually all cells of hematopoietc origin; involved in signal transduction and adhesion.|N||
C0074479|A5805734|AT22537023||MSH|A sialic acid-rich protein and an integral cell membrane mucin. It plays an important role in activation of T-LYMPHOCYTES.|N||
C0075742|A4076304|AT21445463||CSP|membrane associated enzymes; converts NAD to cyclic ADP ribose; CD (2+) activates second messenger and ADP ribose.|N||
C0075742|A5804738|AT22518679||MSH|A bifunctional enzyme that catalyzes the synthesis and HYDROLYSIS of CYCLIC ADP-RIBOSE (cADPR) from NAD+ to ADP-RIBOSE. It is a cell surface molecule which is predominantly expressed on LYMPHOID CELLS and MYELOID CELLS.|N||
C0075747|A3871675|AT22528196||MSH|T-cell differentiation antigens that serve as the receptors for the B7 antigen (ANTIGENS, CD80) which modulates T-cell lymphokine production.|N||
C0075747|A4076051|AT21446386||CSP|T lymphocyte surface molecule; involved in T cell activation and IL2 production.|N||
C0075747|A8685275|AT60864633||NCI|T-Cell specific surface glycoprotein CD28 (220 aa, 25 kD) is a cell fate protein that is encoded by the human CD28 gene and has roles in regulation of apoptosis and humoral immune response.|N||
C0075747|A8685275|AT63373412||NCI|CD28 encodes a highly glycosylated membrane protein with homology to the Ig superfamily. It also shares significant sequence identity with CTLA-4. Both bind the same ligands, however CTLA-4 binds to B7 with a greater affinity. B7 antigen-presenting cells regulate T-cell activation by delivering antigen-independent stimulatory signals through CD28 and inhibitory signals through CTLA-4. CD28 is found on the membrane of resting T-cells. CD28 undergoes tyrosine phosphorylation after interacting with its ligand, B7. Phosphorylation in the cytoplasmic domain of CD28 allows the recruitment of signaling proteins such as PI3K, GRB2, and GADS via their SH2 domains. (OMIM and NCI)|N||
C0076570|A3873366|AT22516052||MSH|A group of differentiation surface antigens, among the first to be discovered on thymocytes and T-lymphocytes. Originally identified in the mouse, they are also found in other species including humans, and are expressed on brain neurons and other cells.|N||
C0076570|A8681311|AT60857557||NCI|Thy-1 membrane glycoprotein (161 aa, ~18 kDa) is encoded by the human THY1 gene. This protein is membrane anchored and may be involved in synaptogenesis.|N||
C0078056|A2774943|AT18488392||NCI|Human vascular cell adhesion molecule-1 protein (739 aa, ~81 kDa) is encoded by the VCAM-1 gene (VCAM1). The protein is a ligand for integrins, which are specific binding molecules in the extracelullar matrix. VCAM-1 promotes the adhesion of immune cells and it is a molecular target for several pharmaceutical compounds.|N||
C0078056|A3827457|AT22533619||MSH|Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. (From Pigott & Power, The Adhesion Molecule FactsBook, 1993, p154)|N||
C0078056|A3827458|AT21441840||CSP|cytokine induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts and myotubes; important for the recruitment of leukocytes to sites of inflammation.|N||
C0079107|A4107523|AT22529085||MSH|Used with chemicals, biological, and non-biological substances for their composition, structure, characterization, and properties; also used for the chemical composition or content of organs, tissue, tumors, body fluids, organisms, and plants. Excludes chemical analysis and determination of substances for which "analysis" is used; excludes synthesis for which "chemical synthesis" is used; excludes isolation and purification of substances for which "isolation & purification" is used.|N||
C0079164|A5840598|AT22522360||MSH|Used with drugs, chemicals, and biological and physical agents in any disease or physical state that might render their use improper, undesirable, or inadvisable. Used also with contraindicated diagnostic, therapeutic, prophylactic, anesthetic, surgical or other procedures.|N||
C0080024|A3387978|AT22536767||MSH|Autosomal dominant, congenital disorder characterized by localized hypomelanosis of the skin and hair. The most familiar feature is a white forelock presenting in 80 to 90 percent of the patients. The underlying defect is possibly related to the differentiation and migration of melanoblasts, as well as to defective development of the neural crest (neurocristopathy). Piebaldism may be closely related to Waardenburg's syndrome.|N||
C0080092|A3503889|AT22535675||MSH|A receptor for MACROPHAGE COLONY-STIMULATING FACTOR encoded by the c-fms proto-oncogene (GENES, FMS). It contains an intrinsic protein-tyrosine kinase activity. When activated the receptor undergoes autophosphorylation, phosphorylation of down-stream signaling molecules and rapid down-regulation.|N||
C0080092|A8687633|AT60873980||NCI|Macrophage colony-stimulating factor 1 receptor (972 aa, 108 kD) is a cell division process protein that is encoded by the human CSF1R gene and has roles in macrophage differentiation and regulation of cell proliferation.|N||
C0080097|A3504753|AT22534418||MSH|Cell surface glycoproteins on lymphocytes and other leukocytes that mediate adhesion to specialized blood vessels called high endothelial venules. Several different classes of lymphocyte homing receptors have been identified, and they appear to target different surface molecules (addressins) on high endothelial venules in different tissues. The adhesion plays a crucial role in the trafficking of lymphocytes.|N||
C0080188|A3871607|AT22522787||MSH|Carbohydrate antigen which is accumulated in various human cancer tissues and secreted into the blood stream. The carbohydrate moiety can be further modified with fucose or sialic acid. Monoclonal antibodies have been determined which can discriminate each subgroup of this antigen in the sera of cancer patients. Sialyl SSEA-1 antigen is particularly elevated in the sera of patients with a variety of tumors.|N||
C0081714|A5862657|AT22532051||MSH|A widely distributed cell surface transmembrane glycoprotein that stimulates the synthesis of MATRIX METALLOPROTEINASES. It is found at high levels on the surface of malignant NEOPLASMS and may play a role as a mediator of malignant cell behavior.|N||
C0081937|A3871668|AT22527696||MSH|Cell-surface glycoproteins and serine protease, also known as dipeptidyl-peptidase IV, that play a role in T-lymphocyte activation. CD26 binds to adenosine deaminase on the T-cell surface. EC 3.4.14.5|N||
C0081938|A3871746|AT22524573||MSH|Integrin beta-1 chains which are expressed as heterodimers that are noncovalently associated with specific alpha-chains of the CD49 family (CD49a-f). CD29 is expressed on resting and activated leukocytes and is a marker for all of the very late activation antigens on cells. (from: Barclay et al., The Leukocyte Antigen FactsBook, 1993, p164)|N||
C0081939|A2719875|AT60874102||NCI|CD31 antigen (738 aa, 83 kD) is a cell communication protein that is encoded by the human PECAM1 gene and has a role in cell recognition and signal transduction.|N||
C0081939|A3864209|AT22522361||MSH|Cell adhesion molecules present on virtually all monocytes, platelets, and granulocytes. CD31 is highly expressed on endothelial cells and concentrated at the junctions between them.|N||
C0081942|A2649991|AT60864320||NCI|Lymphocyte function-associated antigen 3 (250 aa, 28 kD) is a cell adhesion process protein that is encoded by the human CD58 gene and may have a role in cell-cell adhesion.|N||
C0081942|A3864499|AT22524904||MSH|Glycoproteins with a wide distribution on hematopoietic and non-hematopoietic cells and strongly expressed on macrophages. CD58 mediates cell adhesion by binding to CD2; (ANTIGENS, CD2); and this enhances antigen-specific T-cell activation.|N||
C0082758|A5845306|AT55403800||MSH|A cytokine receptor that acts through the formation of oligomeric complexes of itself with a variety of CYTOKINE RECEPTORS.|N||
C0083032|A2643294|AT18334562||NCI|This protein is a receptor for interleukine 7 (IL7). The function of this receptor requires the interleukin 2 receptor common gamma chain (IL2RG). It has been shown to play a critical role in the V(D)J recombination during lymphocyte development. This protein is also found to control the accessibility of the TCR gamma locus by STAT5 and histone acetylation. Knockout studies in mice suggested that blocking apoptosis is an essential function of this protein during differentiation and activation of T lymphocytes. The functional defects in this protein may be associated with the pathogenesis of the severe combined immunodeficiency (SCID). (from LocusLink)|N||
C0083032|A3504725|AT55404988||MSH|Cell surface receptors that are specific for INTERLEUKIN-7. They are present on T-LYMPHOCYTES and B-LYMPHOCYTE precursors. The receptors are heterodimeric proteins consisting of the INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR COMMON BETA SUBUNIT.|N||
C0083033|A7554805|AT55404596||MSH|A cell surface receptor that specifically mediates the biological effects of INTERLEUKIN-9. The functional IL9 receptor signals through interaction of its cytoplasm domain with JANUS KINASES and requires the INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT for activity.|N||
C0085358|A3872166|AT22535696||MSH|Differentiation antigens found on thymocytes and on cytotoxic and suppressor T-lymphocytes. CD8 antigens are members of the immunoglobulin supergene family and are associative recognition elements in MHC (Major Histocompatibility Complex) Class I-restricted interactions.|N||
C0085358|A4077216|AT21445832||CSP|suppressor T-lymphocyte marker that functions as a receptor for MHC class I antigen.|N||
C0085536|A2677715|AT18341131||NCI|Encoded by Protein Tyrosine Phosphatase Genes, Protein Tyrosine Phosphatases are a group of enzymes that specifically remove tyrosine-bound phosphate groups from many phosphoproteins, including many enzymes phosphorylated by a tyrosine kinase. Together with protein tyrosine kinases, Tyrosine Phosphatases regulate tyrosine phosphorylation and dephosphorylation in cellular signal transduction and may play a role in cell growth control and carcinogenesis. (NCI)|N||
C0085536|A3459563|AT21448282||CSP|dephosphorylates O phosphotyrosine groups in phosphoproteins.|N||
C0085536|A8699901|AT60879588||MSH|An enzyme group that specifically dephosphorylates phosphotyrosyl residues in selected proteins. Together with PROTEIN-TYROSINE KINASE, it regulates tyrosine phosphorylation and dephosphorylation in cellular signal transduction and may play a role in cell growth control and carcinogenesis.|N||
C0104998|A2720012|AT60874156||NCI|CD80 antigen (288 aa, 33 kD) is a cell communication protein that is encoded by the human CD80 gene and has a role in regulation of peptidyl-tyrosine phosphorylation.|N||
C0104998|A3872154|AT22535513||MSH|The natural ligand for the T-cell antigen CD28; (ANTIGENS, CD28); mediating T- and B-cell adhesion. CD80 is expressed on activated B-cells and gamma-interferon-stimulated monocytes. The binding of CD80 to CD28 and CTLA-4 provides a co-stimulatory signal to T-cells and leads to greatly upregulated lymphokine production.|N||
C0108748|A2719826|AT18329413||NCI|Expressed on early B-cells by human CD19 Gene (Ig Superfamily), 95-kDa CD19_Antigen is a type I cell surface protein with 2 extracellular IgC2 domains, a cytoplasmic tail with 9 conserved Tyr residues, and no significant homology with other known proteins. Assembled with BCR, CD19 decreases the threshold for antigen receptor-dependent stimulation of B lymphocyte proliferation and intersects with many intracellular signaling pathways. CD19 functions as an adaptor protein for Src family kinase amplification, crucial for antigen receptor-induced signal transduction. Following BCR/CD19 ligation, LYN (Src kinase) phosphorylates CD19-Y513, binds to the CD19-SH2 domain and phosphorylates CD19-Y482. CD19-pY482 recruits more LYN, leading to LYN phosphorylation and CD19-Y391 phosphorylation. CD19-pY391 recruits VAV, phosphorylated by LYN. (NCI)|N||
C0108748|A3864096|AT22531403||MSH|Differentiation antigens expressed on B-lymphocytes and B-cell precursors. They are involved in regulation of B-cell proliferation.|N||
C0108748|A4075778|AT21445578||CSP|CD antigen expressed on B cell surface; forms signal transduction complex with CD21 (CR2) and CD81 (TAPA-1).|N||
C0108754|A3872023|AT22534904||MSH|The 140 kDa isoform of NCAM (neural cell adhesion molecule) containing a transmembrane domain and short cytoplasmic tail. It is expressed by all lymphocytes mediating non-MHC restricted cytotoxicity and is present on some neural tissues and tumors.|N||
C0108768|A3864070|AT22516155||MSH|Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including monocytes, macrophages, and some granulocytes. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein.|N||
C0108768|A4075620|AT21443921||CSP|CD antigen expressed on surface of monocytes, macrophages, eosinophils, neutrophils; lipopolysaccharide receptor; signals production of tumor necrosis factor.|N||
C0108768|A8685142|AT60864261||NCI|Monocyte Differentiation Antigen CD14 (375 aa, 40 kD) is a cell fate protein that is encoded by the human CD14 gene and has a role in apoptosis and phagocytosis.|N||
C0108768|A8685142|AT63373336||NCI|CD14 is a single-copy gene encoding 2 protein forms: a 50- to 55-kD glycosylphosphatidylinositol-anchored membrane protein (mCD14) and a monocyte or liver-derived soluble serum protein (sCD14) that lacks the anchor. Both molecules are critical for lipopolysaccharide (LPS)-dependent signal transduction, and sCD14 confers LPS sensitivity to cells lacking mCD14. Increased sCD14 levels are associated with inflammatory infectious diseases and high mortality in gram-negative shock. (OMIM)|N||
C0108773|A3871747|AT22528640||MSH|Glycoprotein members of the immunoglobulin superfamily which participate in T-cell adhesion and activation. They are expressed on most peripheral T-lymphocytes, natural killer cells, and thymocytes, and function as co-receptors or accessory molecules in the T-cell receptor complex.|N||
C0108773|A4084175|AT21448868||CSP|leukocyte surface antigen long known as the sheep red blood cell receptor (SRBCR); involved in helper and cytotoxic T lymphocyte activation.|N||
C0108773|A8685276|AT60864147||NCI|T-cell surface antigen CD2 (351 aa, 39 kD) is a cell fate protein that is encoded by the human CD2 gene and has a role in induction of apoptosis.|N||
C0108773|A8685276|AT60864559||NCI|An antigen that functions as a co-receptor or accessory molecule in the T-cell receptor complex, which is involved in helper and cytotoxic T-lymphocyte adhesion and activation. The molecule is expressed on the cell surface of the majority of peripheral T-lymphocytes, NK cells, and thymocytes.|N||
C0108779|A2719902|AT18341504||NCI|Consisting of cell surface type I membrane Delta, Epsilon, Gamma, Zeta, and Eta protein subunits with ITAM domains and noncovalently associated with the disulfide bound heterodimeric alpha/beta and gamma/delta TCR, the CD3 complex couples receptor antigen recognition to signal transduction pathways during T-cell activation. During TCR engagement with MHC-associated antigen on host cell surfaces and synapse formation, CD3 activity leads to Tyr-phosphorylated CD3 subunits, Tyr phosphorylation of LAT colocalized in lipid rafts, and MAPK activation. CD3 signal transduction appears to involve LCK, ZAP70, Nck, SLA, SLA2, and DOCK2. CD3 subunits may also associate with the cytoskeleton. CD3 also mediates TCR signal transduction during the developmental transition through positive selection of immature thymocytes to mature CD4+ or CD8+ T cells. (NCI)|N||
C0108779|A3871775|AT22525547||MSH|Complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL). The CD3 complex includes the gamma, delta, epsilon, zeta, and eta chains (subunits). When antigen binds to the T-cell receptor, the CD3 complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 gamma and delta chains (subunits) are separate from and not related to the gamma/delta chains of the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA).|N||
C0108779|A4076429|AT21444790||CSP|T-lymphocyte marker that functions as a molecular bridge holding the T-cell antigen receptor to the cell surface, and coupling antigen- TCR binding to T-cell activation events.|N||
C0108793|A3872018|AT22533256||MSH|Glycoproteins broadly distributed among hematopoietic and non-hematopoietic cells. CD55 prevents the assembly of C3 convertase or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex.|N||
C0108793|A4240381|AT21446377||CSP|intrinsic red blood cell protein that prevents the assembly of convertase on the cell surface, thus protecting the cell from injury by autologous complement.|N||
C0115305|A2739284|AT18325904||NCI|Cell adhesion molecule and CD antigen that mediates neutrophil, monocyte, and memory T-cell adhesion to cytokine-activated endothelial cells. E-selectin recognizes sialylated carbohydrate groups related to the Lewis X or Lewis A family.|N||
C0115305|A2739284|AT18338363||NCI|Encoded by human SELE Gene (Selectin Family), 610-aa 66.5-kD E-Selectin precursor is a cytokine-induced endothelia type I membrane protein with features homologous to LYAM1: a C-type lectin domain, an EGF-like domain, six cysteine-containing SCR (sushi) domains. Likely having an evolutionary history with LYAM1, GRMP, and complement binding proteins, ELAM1 mediates cell adhesion binding of endothelial cells to leukocytes, such as Neutrophils, during inflammatory responses. ELAM1 recognizes glycolipid polylactosamine derivatives and may be involved in the pathogenesis of atherosclerosis. An aa149 polymorphism is associated with higher risk of coronary artery disease and ELAM1 is a diagnostic indicator of glaucoma. (from LocusLink, Swiss-Prot, OMIM, and NCI)|N||
C0115305|A2739284|AT18340148||NCI|E-Selectin is expressed by cytokine-stimulated endothelial cells and is thought responsible for accumulation of neutrophils, monocytes, and memory T-cells at sites of inflammation. Neutrophil accumulation at sites of inflammation is mediated by cell adhesion molecules including the CD18 integrins on leukocytes and the selectins (P- and E-selectin on endothelium and L-selectin on leukocytes). E-Selectin exhibits homologous structural features to L-selectin, including lectin- and EGF-like domains followed by SCR domains. E-Selectin recognizes Lewis X family- or Lewis A family-related sialylated carbohydrate groups. (from OMIM 131210 and NCI)|N||
C0115305|A4379811|AT22517186||MSH|Cell adhesion molecule and CD antigen that mediates neutrophil, monocyte, and memory T-cell adhesion to cytokine-activated endothelial cells. E-selectin recognizes sialylated carbohydrate groups related to the Lewis X or Lewis A family.|N||
C0123242|A3490938|AT22537034||MSH|Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI).|N||
C0123263|A3490941|AT22520716||MSH|Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor).|N||
C0125271|A5864154|AT22530934||MSH|An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. In PLATELETS and T-LYMPHOCYTES it may play a role in the cellular degranulation process.|N||
C0125272|A5704234|AT22519813||MSH|An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. Loss of expression of lysosomal-associated membrane protein 2 is associated with GLYCOGEN STORAGE DISEASE TYPE IIB.|N||
C0134835|A2677967|AT60864218||NCI|P-selectin (830 aa, 91 kD) is a cell adhesion process protein that is encoded by the human SELP gene and has a role in cell adhesion.|N||
C0134835|A3463042|AT22527491||MSH|Cell adhesion molecule and CD antigen that mediates the adhesion of neutrophils and monocytes to activated platelets and endothelial cells.|N||
C0162448|A2828018|AT22536693||MSH|Derivatives of phosphatidic acid in which the hydrophobic regions are composed of two fatty acids and a polar alcohol is joined to the C-3 position of glycerol through a phosphodiester bond. They are named according to their polar head groups, such as phosphatidylcholine and phosphatidylethanolamine.|N||
C0162448|A3379153|AT21441844||CSP|phospholipid in which the phosphate group of a phosphatidic acid is joined in ester linkage to an alcohol moiety; major components of cell membranes.|N||
C0167627|A4084458|AT55403767||MSH|A membrane glycoprotein and differentiation antigen expressed on the surface of T-cells that binds to CD40 ANTIGENS on B-LYMPHOCYTES and induces their proliferation. Mutation of the gene for CD40 ligand is a cause of HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1.|N||
C0167627|A8685967|AT60873904||NCI|CD40 ligand (261 aa, 29 kD) is a cellular division process protein that is encoded by the human CD40LG gene and has roles in inflammatory response, B-cell proliferation and anti-apoptosis.|N||
C0175676|A3803446|AT22519677||MSH|Used with organs and regions for ultrasonic imaging and with diseases for ultrasonic diagnosis. Does not include ultrasonic therapy.|N||
C0205466|A3850148|AT22528354||MSH|Used with organs, animals, and higher plants and with diseases for virologic studies. For bacteria, rickettsia, and fungi, "microbiology" is used; for parasites, "parasitology" is used.|N||
C0205468|A5732488|AT22519282||MSH|Used with animals, higher plants, organs, and diseases for parasitic factors. In diseases, it is not used if the parasitic involvement is implicit in the diagnosis.|N||
C0205469|A3340353|AT22532454||MSH|Used for organ, tissue, or cell structure in disease states.|N||
C0214721|A7559474|AT55403971||MSH|A member of the tumor necrosis factor receptor superfamily that is specific for 4-1BB LIGAND. It is found in a variety of immune cell types including activated T-LYMPHOCYTES; NATURAL KILLER CELLS; and DENDRITIC CELLS. Activation of the receptor on T-LYMPHOCYTES plays a role in their expansion, production of cytokines and survival. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.|N||
C0215991|A7548996|AT55404584||MSH|A transmembrane protein belonging to the tumor necrosis factor superfamily that specifically binds to CD27 ANTIGEN. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; and DENDRITIC CELLS where it plays a role in stimulating the proliferation of CD4-POSITIVE T-LYMPHOCYTES and CD8-POSITIVE T-LYMPHOCYTES.|N||
C0218093|A7549627|AT55404761||MSH|A membrane-bound tumor necrosis family member found primarily on activated T-LYMPHOCYTES that binds specifically to CD30 ANTIGEN. It may play a role in INFLAMMATION and immune regulation.|N||
C0220248|A5805735|AT22519857||MSH|A ubiquitously expressed membrane glycoprotein. It interacts with a variety of INTEGRINS and mediates responses to EXTRACELLULAR MATRIX PROTEINS.|N||
C0220248|A5827694|AT21447187||CSP|transmembrane protein without tissue specificity that is involved in membrane cation flux.|N||
C0220248|A8685774|AT60874116||NCI|Leukocyte Surface Antigen CD47 (323 aa, 35 kD) is a cellular division process protein that is encoded by the human CD47 gene and has roles in positive regulation of cell-cell adhesion, positive regulation of cell proliferation and positive regulation of T cell activation.|N||
C0231170|A2733564|AT18322731||NCI|Any physical, mental, or functional impairment that limits a major activity. It may be partial or complete. (Taber's)|N||
C0231170|A7322924|AT53147902||HL7V3.0|<p>A person becomes a claimant under a disability income insurance policy or a disability rehabilitation program because of a health condition or injury which limits the person's ability to earn an income or function without institutionalization. </p>|N||
C0242354|A4182767|AT21446735||CSP|existing at, and usually before, birth; referring to conditions that are present at birth, regardless of their causation; inborn metabolism disorders are generally not treed here.|N||
C0243192|A2668775|AT50020910||NCI|An agent that has affinity for a receptor and intrinsic activity at that receptor.|N||
C0243192|A3298110|AT22534548||MSH|Used with chemicals, drugs, and endogenous substances to indicate substances or agents that have affinity for a receptor and intrinsic activity at that receptor. (From Textbook of Pharmacology, 1991, p.16)|N||
C0245662|A2700434|AT60874069||NCI|Tumor necrosis factor receptor superfamily member 6 (335 aa, 38 kD) is a cell fate protein that is encoded by the human FAS gene and has roles in signal transduction, induction of apoptosis, and prevention of apoptosis.|N||
C0245662|A2700434|AT63373384||NCI|FAS differentiation antigen is expressed in the thymus, liver, ovary, and heart, and on a variety of cell lines including myeloid and lymphoblastoid cell lines. Its primary role is to regulate T-cell development in the thymus and to regulate peripheral immune responses, by triggering apoptosis. FAS is a member of the TNFR/NGFR superfamily. Activation of FAS by FAS ligand results in the formation of a death-inducing signaling complex with the signal adaptor protein FADD and with procaspase 8. This association generates CASP8, activating a cascade of caspases. (OMIM and NCI)|N||
C0245662|A3872178|AT55404161||MSH|A tumor necrosis factor receptor subtype found in a variety of tissues and on activated LYMPHOCYTES. It has specificity for FAS LIGAND and plays a role in regulation of peripheral immune responses and APOPTOSIS. Multiple isoforms of the protein exist due to multiple ALTERNATIVE SPLICING. The activated receptor signals via a conserved death domain that associates with specific TNF RECEPTOR-ASSOCIATED FACTORS in the CYTOPLASM.|N||
C0245662|A4077307|AT21446312||CSP|differentiation antigens expressed on a variety of cell lines; regulate peripheral immune responses.|N||
C0245726|A2963362|AT22520879||MSH|An integrin beta subunit of approximately 85-kDa in size which has been found in INTEGRIN ALPHAIIB-containing and INTEGRIN ALPHAV-containing heterodimers. Integrin beta3 occurs as three alternatively spliced isoforms, designated beta3A-C.|N||
C0245726|A8685592|AT60864538||NCI|Integrin beta-3 (788 aa, 87 kD) is a cell adhesion process protein that is encoded by the human ITGB3 gene and has roles in cell adhesion and blood coagulation.|N||
C0248554|A7554810|AT55404958||MSH|A tumor necrosis family receptor with specificity for OX40 LIGAND. It is found on the surface of activated T-LYMPHOCYTES where it plays a role in enhancing cytokine production and proliferation of CD4-POSITIVE T-LYMPHOCYTES. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.|N||
C0249229|A2963215|AT22519587||MSH|An integrin alpha subunit that primarily combines with INTEGRIN BETA1 to form the INTEGRIN ALPHA2BETA1 heterodimer. It contains a domain which has homology to collagen-binding domains found in von Willebrand factor.|N||
C0252194|A2972434|AT22531952||MSH|An integrin alpha subunit that is unique in that it does not contain an I domain, and its proteolytic cleavage site is near the middle of the extracellular portion of the polypeptide rather than close to the membrane as in other integrin alpha subunits.|N||
C0253023|A7550879|AT55404780||MSH|A transmembrane protein belonging to the tumor necrosis factor superfamily that was originally discovered on cells of the lymphoid-myeloid lineage, including activated T-LYMPHOCYTES and NATURAL KILLER CELLS. It plays an important role in immune homeostasis and cell-mediated toxicity by binding to the FAS RECEPTOR and triggering APOPTOSIS.|N||
C0253906|A2642772|AT60864557||NCI|Integrin beta-4 (1822 aa, 202 kD) is a cell adhesion process protein that is encoded by the human ITGB4 gene and has a role in cell adhesion.|N||
C0253906|A2963367|AT22516763||MSH|Also known as CD104 antigen, this protein is distinguished from other beta integrins by its relatively long cytoplasmic domain (approximately 1000 amino acids vs. approximately 50). Five alternatively spliced isoforms have been described.|N||
C0253930|A2963338|AT22532613||MSH|An alpha integrin with a molecular weight of 160-kDa that is found in a variety of cell types. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds. Integrin alphaV can combine with several different beta subunits to form heterodimers that generally bind to RGD sequence-containing extracellular matrix proteins.|N||
C0254613|A2963212|AT22532547||MSH|An integrin alpha subunit that binds COLLAGEN and LAMININ though its I domain. It combines with INTEGRIN BETA1 to form the heterodimer INTEGRIN ALPHA1BETA1.|N||
C0255808|A2700430|AT18330417||NCI|TNFR1 is a 55 kD high-affinity cell surface receptor for tumor necrosis factor. Activated receptor interacts with death domains of TRADD to activate apoptosis and NFKB cascades. TRADD-interacting FADD proteolytically activates caspase-8. TNFR1 may activate PIP5K2B and may induce MAP kinase activation via MADD. (from OMIM 191190 and NCI)|N||
C0255808|A2700430|AT18338836||NCI|This protein is a member of the TNF-receptor superfamily. It is one of the major receptors for the tumor necrosis factor-alpha. This receptor can activate NF-kappaB, mediate apoptosis, and function as a regulator of inflammation. Antiapoptotic protein BCL2-associated athanogene 4 (BAG4/SODD) and adaptor proteins TRADD and TRAF2 have been shown to interact with this receptor, and thus play regulatory roles in the signal transduction mediated by the receptor. Germline mutations of the extracellular domains of this receptor were found to be associated with the autosomal dominant periodic fever syndrome. The impaired receptor clearance is thought to be a mechanism of the disease. (LocusLink)|N||
C0255808|A3505127|AT55404983||MSH|A tumor necrosis factor receptor subtype that has specificity for TUMOR NECROSIS FACTOR ALPHA and LYMPHOTOXIN ALPHA. It is constitutively expressed in most tissues and is a key mediator of tumor necrosis factor signaling in the vast majority of cells. The activated receptor signals via a conserved death domain that associates with specific TNF RECEPTOR-ASSOCIATED FACTORS in the CYTOPLASM.|N||
C0255813|A2700431|AT18332314||NCI|TNFR2 is a 70 kD high-affinity cell surface receptor for tumor necrosis factor. TNFBR is the larger of the two TNF receptors, has a single membrane-spanning domain, and has an extracellular domain with sequence similarity to NGF receptor and B-cell activation protein BP50. TNFBR is present on many cell types, especially of myeloid origin, and is strongly expressed on stimulated T- and B-lymphocytes. TNFBR is the main TNF receptor on circulating T-cells and the major mediator of autoregulatory apoptosis in CD8+ cells. TNFBR may act with TNFR1 to kill nonlymphoid cells. (from OMIM 191191 and NCI)|N||
C0255813|A2700431|AT18342731||NCI|A 70-kDa high-affinity cell surface receptor for tumor necrosis factor.|N||
C0255813|A3505128|AT22515590||MSH|A tumor necrosis factor receptor subtype that is expressed primarily in IMMUNE SYSTEM cells. It has specificity for membrane-bound form of TUMOR NECROSIS FACTORS and mediates intracellular-signaling through TNF RECEPTOR ASSOCIATED FACTORS.|N||
C0285488|A5804739|AT22519132||MSH|A ubiquitously expressed complement receptor that binds COMPLEMENT C3B and COMPLEMENT C4B and serves as a cofactor for their inactivation. CD46 also interacts with a wide variety of pathogens and mediates immune response.|N||
C0285862|A3872182|AT22523462||MSH|A heterodimeric protein that is a cell surface antigen associated with lymphocyte activation. The initial characterization of this protein revealed one identifiable heavy chain (ANTIGENS, CD98 HEAVY CHAIN) and an indeterminate smaller light chain. It is now known that a variety of light chain subunits (ANTIGENS, CD98 LIGHT CHAINS) can dimerize with the heavy chain. Depending upon its light chain composition a diverse array of functions can be found for this protein. Functions include: type L amino acid transport, type y+L amino acid transport and regulation of cellular fusion.|N||
C0286983|A2645272|AT18329850||NCI|Kangai 1 Protein, a metastasis suppressor protein encoded by the 80 kb human KAI1 gene (TM4SF family), is expressed in many tissues and has four putative transmembrane domains and a large extracellular domain having three potential N-glycosylation sites. KAI1 appears to be up regulated in activated T-cells. p53 activates the gene by interacting with sequences in a 5-prime upstream region. Loss of p53 appears to cause down-regulation of KAI1. Similar to leukocyte cell surface glycoproteins involved in cell adhesion and signal transduction, KAI1 is a likely homologue of mouse leukocyte surface antigen R2. Associated with CD4 or CD8, KAI1 delivers co-stimulatory signals for the TCR/CD3 pathway. KAI1 expression at the transcription or posttranscription level is often down regulated during tumor progression. (from SWISS-PROT, OMIM, and NCI)|N||
C0286983|A5644495|AT22513698||MSH|A widely expressed transmembrane glycoprotein that functions as a METASTASIS suppressor protein. It is under-expressed in a variety of human NEOPLASMS.|N||
C0287186|A2743588|AT18340373||NCI|Fms-related receptor tyrosine kinase; growth factor receptor for hematopoietic stem and progenitor cells. (LocusLink)|N||
C0287186|A5862379|AT22530404||MSH|A receptor tyrosine kinase that is involved in HEMATOPOIESIS. It is closely related to FMS PROTO-ONCOGENE PROTEIN and is commonly mutated in acute MYELOID LEUKEMIA.|N||
C0289325|A2963233|AT22513652||MSH|An integrin alpha subunit that primarily associates with INTEGRIN BETA1 or INTEGRIN BETA4 to form laminin-binding heterodimers. Integrin alpha6 has two alternatively spliced isoforms: integrin alpha6A and integrin alpha6B, which differ in their cytoplasmic domains and are regulated in a tissue-specific and developmental stage-specific manner.|N||
C0295967|A2719806|AT60864327||NCI|CD166 antigen (583 aa, 65 kD) is a cell adhesion process protein that is encoded by the human ALCAM gene and has a role in cell adhesion.|N||
C0295967|A3080154|AT22529352||MSH|Cell adhesion molecule expressed on activated leukocytes, fibroblasts, and neurons. It is a ligand for CD6. ALCAM-CD6 interactions may play a role in the binding of T and B cells to activated leukocytes.|N||
C0297434|A2963219|AT22533539||MSH|An integrin alpha subunit that occurs as alternatively spliced isoforms. The isoforms are differentially expressed in specific cell types and at specific developmental stages. Integrin alpha3 combines with INTEGRIN BETA1 to form INTEGRIN ALPHA3BETA1 which is a heterodimer found primarily in epithelial cells.|N||
C0298340|A2642759|AT60864082||NCI|Integrin alpha 5 (1049 aa, 115 kD) is a cell adhesion process protein that is encoded by the human ITGA5 gene and has a role in cell adhesion.|N||
C0298340|A2963224|AT22520016||MSH|This integrin alpha subunit combines with INTEGRIN BETA1 to form a receptor (INTEGRIN ALPHA5BETA1) that binds FIBRONECTIN and LAMININ. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds.|N||
C0348393|A0418977|AT50097274||PMA|Note: The terms used in categories C82-C85 for non-Hodgkin's lymphomas are those of the Working Formulation, which attempted to find common ground among several major classification schemes. The terms used in these schemes are not given in the Tabular List but appear in the Alphabetical Index; exact equivalence with the terms appearing in the Tabular List is not always possible. Includes: morphology codes M959-M994 with behaviour code /3 Excludes: secondary and unspecified neoplasm of lymph nodes ( C77.- ) C81 Hodgkin's disease Includes: morphology codes M965-M966 with behaviour code /3 C81.0 Lymphocytic predominance Lymphocytic-histiocytic predominance C81.1 Nodular sclerosis C81.2 Mixed cellularity C81.3 Lymphocytic depletion C81.7 Other Hodgkin's disease C81.9 Hodgkin's disease, unspecified C82 Follicular [nodular] non-Hodgkin's lymphoma Includes: follicular non-Hodgkin's lymphoma with or without diffuse areas morphology code M969 with behaviour code /3 C82.0 Small cleaved cell, follicular C82.1 Mixed small cleaved and large cell, follicular C82.2 Large cell, follicular C82.7 Other types of follicular non-Hodgkin's lymphoma C82.9 Follicular non-Hodgkin's lymphoma, unspecified Nodular non-Hodgkin's lymphoma NOS C83 Diffuse non-Hodgkin's lymphoma Includes: morphology codes M9593, M9595, M967-M968 with behaviour code /3 C83.0 Small cell (diffuse) C83.1 Small cleaved cell (diffuse) C83.2 Mixed small and large cell (diffuse) C83.3 Large cell (diffuse) Reticulum cell sarcoma C83.4 Immunoblastic (diffuse) C83.5 Lymphoblastic (diffuse) C83.6 Undifferentiated (diffuse) C83.7 Burkitt's tumour C83.8 Other types of diffuse non-Hodgkin's lymphoma C83.9 Diffuse non-Hodgkin's lymphoma, unspecified C84 Peripheral and cutaneous T-cell lymphomas Includes: morphology code M970 with behaviour code /3 C84.0 Mycosis fungoides C84.1 Sezary's disease C84.2 T-zone lymphoma C84.3 Lymphoepithelioid lymphoma Lennert's lymphoma C84.4 Peripheral T-cell lymphoma C84.5 Other and unspecified T-cell lymphomas Note: If T-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description. C85 Other and unspecified types of non-Hodgkin's lymphoma Includes: morphology codes M9590-M9592, M9594, M971 with behaviour code /3 C85.0 Lymphosarcoma C85.1 B-cell lymphoma, unspecified Note: If B-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description. C85.7 Other specified types of non-Hodgkin's lymphoma Malignant: reticuloendotheliosis reticulosis Microglioma C85.9 Non-Hodgkin's lymphoma, unspecified type Lymphoma NOS Malignant lymphoma NOS Non-Hodgkin's lymphoma NOS C88 Malignant immunoproliferative diseases Includes: morphology code M976 with behaviour code /3 C88.0 Waldenstrom's macroglobulinaemia C88.1 Alpha heavy chain disease C88.2 Gamma heavy chain disease Franklin's disease C88.3 Immunoproliferative small intestinal disease Mediterranean disease C88.7 Other malignant immunoproliferative diseases C88.9 Malignant immunoproliferative disease, unspecified Immunoproliferative disease NOS C90 Multiple myeloma and malignant plasma cell neoplasms Includes: morphology codes M973, M9830 with behaviour code /3 C90.0 Multiple myeloma Kahler's disease Myelomatosis Excludes: solitary myeloma ( C90.2 ) C90.1 Plasma cell leukaemia C90.2 Plasmacytoma, extramedullary Malignant plasma cell tumour NOS Plasmacytoma NOS Solitary myeloma C91 Lymphoid leukaemia Includes: morphology codes M982, M9940-M9941 with behaviour code /3 C91.0 Acute lymphoblastic leukaemia Excludes: acute exacerbation of chronic lymphocytic leukaemia ( C91.1 ) C91.1 Chronic lymphocytic leukaemia C91.2 Subacute lymphocytic leukaemia C91.3 Prolymphocytic leukaemia C91.4 Hairy-cell leukaemia Leukaemic reticuloendotheliosis C91.5 Adult T-cell leukaemia C91.7 Other lymphoid leukaemia C91.9 Lymphoid leukaemia, unspecified C92 Myeloid leukaemia Includes: leukaemia: granulocytic myelogenous morphology codes M986-M988, M9930 with behaviour code /3 C92.0 Acute myeloid leukaemia Excludes: acute exacerbation of chronic myeloid leukaemia ( C92.1 ) C92.1 Chronic myeloid leukaemia C92.2 Subacute myeloid leukaemia C92.3 Myeloid sarcoma Chloroma Granulocytic sarcoma C92.4 Acute promyelocytic leukaemia C92.5 Acute myelomonocytic leukaemia C92.7 Other myeloid leukaemia C92.9 Myeloid leukaemia, unspecified C93 Monocytic leukaemia Includes: monocytoid leukaemia morphology code M989 with behaviour code /3 C93.0 Acute monocytic leukaemia Excludes: acute exacerbation of chronic monocytic leukaemia ( C93.1 ) C93.1 Chronic monocytic leukaemia C93.2 Subacute monocytic leukaemia C93.7 Other monocytic leukaemia C93.9 Monocytic leukaemia, unspecified C94 Other leukaemias of specified cell type Includes: morphology codes M984, M9850, M9900, M9910, M9931-M9932 with behaviour code /3 Excludes: leukaemic reticuloendotheliosis ( C91.4 ) plasma cell leukaemia ( C90.1 ) C94.0 Acute erythraemia and erythroleukaemia Acute erythraemic myelosis Di Guglielmo's disease C94.1 Chronic erythraemia Heilmeyer-Schoner disease C94.2 Acute megakaryoblastic leukaemia Leukaemia: megakaryoblastic (acute) megakaryocytic (acute) C94.3 Mast cell leukaemia C94.4 Acute panmyelosis C94.5 Acute myelofibrosis C94.7 Other specified leukaemias Lymphosarcoma cell leukaemia C95 Leukaemia of unspecified cell type Includes: morphology code M980 with behaviour code /3 C95.0 Acute leukaemia of unspecified cell type Blast cell leukaemia Stem cell leukaemia Excludes: acute exacerbation of unspecified chronic leukaemia ( C95.1 ) C95.1 Chronic leukaemia of unspecified cell type C95.2 Subacute leukaemia of unspecified cell type C95.7 Other leukaemia of unspecified cell type C95.9 Leukaemia, unspecified C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue Includes: morphology codes M972, M974 with behaviour code /3 C96.0 Letterer-Siwe disease Nonlipid: reticuloendotheliosis reticulosis C96.1 Malignant histiocytosis Histiocytic medullary reticulosis C96.2 Malignant mast cell tumour Malignant: mastocytoma mastocytosis Mast cell sarcoma Excludes: mast cell leukaemia ( C94.3 ) mastocytosis (cutaneous) ( Q82.2 ) C96.3 True histiocytic lymphoma C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue C96.9 Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified - SOURCE: International Statistical Classification of Diseases and Related Health Problems - 10th Revision - Version for 2003 (http://www3.who.int/icd/vol1htm2003/fr-icd.htm)|N||
C0382839|A5861876|AT22534098||MSH|A C-type lectin that associates with NKG2 proteins to form receptors for HLA-E antigen on NATURAL KILLER CELLS.|N||
C0382839|A8685803|AT60873957||NCI|Natural killer cells antigen CD94 (179 aa, 20 kD) is a cell communication protein that is encoded by the human KLRD1 gene and has a role in cell surface receptor-linked signal transduction.|N||
C0388580|A7554789|AT55404420||MSH|An interleukin-1 receptor subtype that competes with the INTERLEUKIN-1 RECEPTOR TYPE I for binding to INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The interleukin-1 type II receptor appears to lack signal transduction capability. Therefore it may act as a "decoy" receptor that modulates the activity of its ligands. Both membrane-bound and soluble forms of the receptor have been identified.|N||
C0391754|A7554790|AT55404217||MSH|An interleukin-1 receptor subtype that is involved in signaling cellular responses to INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The binding of this receptor to its ligand causes its favorable interaction with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN and the formation of an activated receptor complex.|N||
C0392207|A2936195|AT21443040||CSP|genetically or developmently determined deficiency of immune response or disorder that is characterized by deficient immune response.|N||
C0524914|A2722398|AT18333404||NCI|Encoded by Chemokine Receptor Genes (GPCR Family), cell surface Chemokine Receptors are seven-transmembrane G protein-coupled receptor glycoproteins that bind to chemokines and mediate the migration of pro-inflammatory cells. Like chemokines, the chemokine receptors can be divided, according to variations in a shared cysteine motif, into at least three structural branches: CR, CCR, and CXCR. (NCI)|N||
C0524914|A3490667|AT22520762||MSH|Cell surface glycoproteins that bind to chemokines and thus mediate the migration of pro-inflammatory molecules. The receptors are members of the seven-transmembrane G protein-coupled receptor family. Like the CHEMOKINES themselves, the receptors can be divided into at least three structural branches: CR, CCR, and CXCR, according to variations in a shared cysteine motif.|N||
C0524914|A4107726|AT21444997||CSP|cell surface glycoproteins that bind to chemokines and thus mediate the migration of proinflammatory molecules; members of the seven transmembrane G protein coupled receptor family; the receptors can be divided into at least three structural branches: CR, CCR, and CXCR.|N||
C0525040|A3117335|AT22513543||MSH|Those psychiatric disorders usually first diagnosed in infancy, childhood, or adolescence. These disorders can also be first diagnosed during other life stages.|N||
C0526339|A2643298|AT60874010||NCI|High Affinity Interleukin-8 Receptor A (350 aa, 40 kD) is a cell motility protein that is encoded by the human IL8RA gene and has roles in inflammatory response, chemotaxis and signal transduction.|N||
C0526339|A2643298|AT63373211||NCI|Interleukin-8 is a member of a family of pro-inflammatory cytokines. The best-characterized activities of IL8 include the chemoattraction and activation of neutrophils. There are two IL8 receptors, type 1 (alpha) and type 2 (beta). The type 1 IL8 receptor binds only IL8, while the type 2 IL8 receptor binds also GRO and NAP-2. (OMIM)|N||
C0526339|A3504727|AT55404176||MSH|High-affinity G-protein-coupled receptors for INTERLEUKIN-8 present on NEUTROPHILS; MONOCYTES; and BASOPHILS.|N||
C0527729|A7552046|AT55404215||MSH|An interleukin receptor subunit with specificity for INTERLEUKIN-13. It dimerizes with the INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT to form the TYPE II INTERLEUKIN-4 RECEPTOR which has specificity for both INTERLEUKIN-4 and INTERLEUKIN-13. Signaling of this receptor subunit occurs through the interaction of its cytoplasmic domain with JANUS KINASES such as the TYK2 KINASE.|N||
C0527903|A5805738|AT22529972||MSH|A CD antigen that plays a role in T-lymphocyte proliferation and interleukin 2 production. It is a co-stimulatory ligand for the CD28 ANTIGEN on T-LYMPHOCYTES and initiates T-cell activation and immune response.|N||
C0549567|A3385682|AT21449327||CSP|disorders of pigmentation of the skin and other organs, including discoloration, hyperpigmentation and hypopigmentation.|N||
C0728866|A5858093|AT22521795||MSH|Used with organs, regions, tissues, or organisms and physiological and psychological processes for the effects of drugs and chemicals.|N||
C0748408|A2682769|AT18335252||NCI|Inflammatory and degenerative diseases of connective tissue structures, such as arthritis.|N||
C0748408|A2725900|AT18507311||NCI-GLOSS|A term previously used to describe chronic diseases of the connective tissue (e.g., rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis), but now is thought to be more appropriate for diseases associated with defects in collagen, which is a component of the connective tissue.|N||
C0748408|A4149951|AT22529404||MSH|Historically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that "collagen" was equivalent to "connective tissue", but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term "collagen diseases" now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. (From Cecil Textbook of Medicine, 19th ed, p1494)|N||
C0748408|A4149952|AT21442321||CSP|pertains to those conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly.|N||
C0916861|A5805732|AT22515694||MSH|A sialomucin protein that functions as a cell adhesion molecule. It is a negative regulator of certain types of HEMATOPOIETIC STEM CELLS.|N||
C0950133|A2773052|AT43088994||NCI|This database is a catalog of human genes and genetic disorders authored and edited by Dr. Victor A. McKusick and his colleagues at Johns Hopkins and elsewhere, and developed for the World Wide Web by NCBI, the National Center for Biotechnology Information. The database contains textual information and references. It also contains copious links to MEDLINE and sequence records in the Entrez system, and links to additional related resources at NCBI and elsewhere.|N||
C0968296|A7552048|AT55404544||MSH|An interleukin-13 receptor subunit that is closely-related to the INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT. The receptor is found as a monomeric protein and has been considered to be a decoy receptor for interleukin-13 due the fact that it lacks cytoplasmic signaling domains.|N||
C0971508|A8700376|AT60880645||MSH|A KIR receptor that has specificity for HLA-A3 ANTIGEN. It is an inhibitory receptor that contains D0, D1, and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.|N||
C0995203|A2754122|AT43089491||NCI|Established in 1988 as a national resource for molecular biology information, NCBI creates public databases, conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information - all for the better understanding of molecular processes affecting human health and disease.|N||
C0995203|A7062098|AT52064706||MGED|identifier for a taxon provided by the NCBI taxonomy database|N||
C1101536|A7552080|AT55404707||MSH|A low affinity interleukin-2 receptor subunit that combines with the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN to form a high affinity receptor for INTERLEUKIN-2.|N||
C1101536|A8685627|AT60874227||NCI|Interleukin-2 receptor alpha chain (272 aa, 31 kD) is a cell fate protein that is encoded by the human IL2RA gene and has roles in immune response, cell proliferation, apoptosis and signal transduction.|N||
C1101536|A8685627|AT63373122||NCI|The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolysis. (LocusLink)|N||
C1135584|A3108610|AT22513668||MSH|Controlled vocabulary thesaurus produced by the NATIONAL LIBRARY OF MEDICINE. It consists of sets of terms naming descriptors in a hierarchical structure that permits searching at various levels of specificity.|N||
C1135584|A7062090|AT52064144||MGED|database entry from MESH, medical subject headings vocabulary resource|N||
C1136323|A2801127|AT63377052||CDISC|Published by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)|N||
C1136323|A2810819|AT63377894||NCI|Published by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology.|N||
C1136323|A4508261|AT22536181||MSH|A vocabulary database of universal identifiers for laboratory and clinical test results. Its purpose is to facilitate the exchange and pooling of results for clinical care, outcomes management, and research. It is produced by the Regenstrief Institute. (LOINC and RELMA [Internet]. Indianapolis: The Regenstrief Institute; c1995-2001 [cited 2002 Apr 2]. Available from http://www.regenstrief.org/loinc)|N||
C1136323|A7061879|AT52064078||MGED|Database resource for universal identifiers for laboratory and other clinical observations|N||
C1138831|A2745775|AT43089940||NCI|The Gene Ontology (GO) project is a collaborative effort to address the need for consistent descriptions of gene products in different databases. The goal of the Gene Ontology project is to produce a controlled vocabulary that can be applied to all organisms even as knowledge of gene and protein roles in cells is accumulating and changing. GO provides three structured networks of defined terms, molecular function, biological process, and cellular component, to describe gene product attributes.|N||
C1138831|A8254684|AT58499849||GO|OBSOLETE. A controlled vocabulary that can be applied to all organisms even as knowledge of gene and protein roles in cells is accumulating and changing. GO provides three structured networks of defined terms to describe gene product attributes. [GOC:go_curators]|N||
C1140097|A8662003|AT60845556||NCI|A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. It provides a method to deal with the variation in vocabulary used by those who submit adverse event reports to the FDA.|N||
C1140120|A5705468|AT21529597||HL7V3.0|Universal Medical Device Nomenclature System. ECRI, 5200 Butler Pike, Plymouth Meeting, PA 19462 USA. Phone: 215-825-6000, Fax: 215-834-1275.|N||
C1140148|A2869296|AT22517640||MSH|Uniform method for health care providers and medical suppliers to report professional services, procedures, and supplies. It consists of alphanumeric codes and modifiers for the use of all public and private health insurers. It is developed by the Centers for Medicare and Medicaid Services.|N||
C1140168|A7062025|AT52063891||MGED|A description logic namespace that contains controlled terminology used at NCI.|N||
C1149918|A7823063|AT58513101||GO|Catalysis of the reaction: a 5'-ribonucleotide + H2O = a ribonucleoside + phosphate. [EC:3.1.3.5]|N||
C1171258|A5839841|AT22534331||MSH|Used with diseases to indicate conditions that co-exist or follow, i.e., co-existing diseases, complications, or sequelae.|N||
C1173313|A7552083|AT55404292||MSH|A receptor subunit that is a shared component of the INTERLEUKIN 2 RECEPTOR and the INTERLEUKIN-15 RECEPTOR. High affinity receptor complexes are formed with each of these receptors when their respective alpha subunits are combined with this beta subunit and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.|N||
C1173313|A8687537|AT60873887||NCI|IL2 receptor beta (551 aa, 61 kD) is a cell communication process protein that is encoded by the human IL2RB gene and has a role in signal transduction.|N||
C1333105|A2726187|AT18323945||NCI|Colony Stimulating Factor 2 Receptor, Beta, Low-Affinity (CSF2RB), encoded by the CSF2RB gene, is a common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defective CSF2RB has been reported to be associated with protein alveolar proteinosis. (From LocusLink)|N||
C1333105|A7550200|AT55403954||MSH|A receptor subunit that is a shared component of the INTERLEUKIN-3 RECEPTOR; the INTERLEUKIN-5 RECEPTOR; and the GM-CSF RECEPTOR. High affinity receptor complexes are formed with each of these receptors when their respective alpha subunits are combined with this shared beta subunit.|N||
C1334204|A2643201|AT18341809||NCI|The interleukin 2 (IL2) receptor gamma chain (IL2RG) is an important signalling component of many interleukin receptors (e.g., IL2,IL4,IL7,IL9, and IL15) and is thus referred to as the common gamma chain. It is necessary for normal growth and differentiation of T cells, B cells, natural killer cells, glioma cells, and cells of the monocyte lineage. Mutations in this X-chromosome-linked gene cause X-linked severe combined immunodeficiency (XSCID). (from LocusLink and OMIM)|N||
C1334204|A7552010|AT55403839||MSH|An interleukin receptor subunit that was originally discovered as a component of the INTERLEUKIN-2 RECEPTOR. It was subsequently found to be a component of several other receptors including the INTERLEUKIN-4 RECEPTOR, the INTERLEUKIN-7 RECEPTOR, the INTERLEUKIN-9 RECEPTOR, the INTERLEUKIN-15 RECEPTOR, and the INTERLEUKIN-21 RECEPTOR. Mutations in the gene for the interleukin common gamma chain have been associated with X-LINKED COMBINED IMMUNODEFICIENCY DISEASES.|N||
C1371271|A2758084|AT18327110||NCI|Published by the US Veterans' Administration. National Drug File Reference Terminology covers clinical drugs used at the VA.|N||
C1372955|A5864020|AT21530372||HL7V3.0|A therapeutically active ingredient (player) in a mixture (scoper), where the mixture is typically a manufactured pharmaceutical.|N||
C1412043|A2781040|AT18487213||NCI|An international organization of scientists involved in human genetics. Established in 1989 by a collection of the world's leading human geneticists, the primary ethos of the Human Genome Organisation is to promote and sustain international collaboration in the field of human genetics.|N||
C1457876|A5804735|AT22522107||MSH|A cell adhesion molecule of the immunoglobulin superfamily that is expressed in ENDOTHELIAL CELLS and is involved in INTERCELLULAR JUNCTIONS.|N||
C1457898|A5687785|AT22518281||MSH|Used with microorganisms, plants, and the postnatal period of animals for growth and development. It includes also the postnatal growth or development of organs or anatomical parts.|N||
C1510467|A5696380|AT22528130||MSH|Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which "pathology" is used.|N||
C1512849|A7552125|AT55404986||MSH|A low affinity interleukin-6 receptor subunit that combines with the CYTOKINE RECEPTOR GP130 to form a high affinity receptor for INTERLEUKIN-6.|N||
C1516728|A2804723|AT43089721||NCI|A standard terminology developed to report adverse events occurring in cancer clinical trials. Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration. The CTCAE contain a grading scale for each adverse event term representing the severity of the event.|N||
C1522005|A2942680|AT22536925||MSH|Used for immunologic studies of tissues, organs, microorganisms, fungi, viruses, and animals. It includes immunologic aspects of diseases but not immunologic procedures used for diagnostic, preventive, or therapeutic purposes, for which "diagnosis", "prevention & control", or "therapy" are used. The concept is also used for chemicals as antigens or haptens.|N||
C1522484|A5767749|AT22526262||MSH|Used with neoplasms to indicate the secondary location to which the neoplastic process has metastasized.|N||
C1524024|A5772379|AT22521004||MSH|Used for the identification or quantitative determination of a substance or its constituents and metabolites; includes the analysis of air, water, or other environmental carrier. It excludes the chemical analysis of tissues, tumors, body fluids, organisms, and plants for which "chemistry" is used. The concept applies to both methodology and results. For analysis of substances in blood, cerebrospinal fluid, and urine the specific subheading designating the fluid is used.|N||
C1524059|A3370199|AT22520853||MSH|Used with drugs and exogenously administered chemical substances for their effects on living tissues and organisms. It includes acceleration and inhibition of physiological and biochemical processes and other pharmacologic mechanisms of action.|N||
C1524060|A3471441|AT22519495||MSH|Used with non-psychiatric diseases, techniques, and named groups for psychologic, psychiatric, psychosomatic, psychosocial, behavioral, and emotional aspects, and with psychiatric disease for psychologic aspects; used also with animal terms for animal behavior and psychology.|N||
C1527243|A4382988|AT22531729||MSH|Used with techniques and activities for discussion and analysis with respect to human and social values.|N||
C1533645|A5805736|AT22518307||MSH|A component of the B-cell antigen receptor that is involved in B-cell antigen receptor heavy chain transport to the PLASMA MEMBRANE. It is expressed almost exclusively in B-LYMPHOCYTES and serves as a useful marker for B-cell NEOPLASMS.|N||
C1546211|A5736886|AT21530429||HL7V3.0|The PNDS provides standardized terms and codes for patient problems/nursing diagnoses, nursing interventions including actual or expected (goal) outcomes. The PNDS provides standardized terms and codes for nursing diagnoses (a subset of NANDA), nursing interventions and outcomes. The outcomes and interventions are in a relational database. The PNDS intervention and outcome statements are attached in an Access Database. The NANDA diagnoses in the PNDS have already been registered by HL7.|N||
C1609432|A2933029|AT21447842||CSP|diseases or abnormal states of the immune system.|N||
C1609943|A7555485|AT55403962||MSH|A syndecan that interacts with EXTRACELLULAR MATRIX PROTEINS and plays a role CELL PROLIFERATION and CELL MIGRATION.|N||
C1619351|A2965670|AT22517174||MSH|Used with organs, regions, or tissues for their nerve supply.|N||
C1623416|A5846557|AT22515178||MSH|Used with endogenous and exogenous substances which are absent or in diminished amount relative to the normal requirement of an organism or a biologic system.|N||
C1623497|A2806296|AT18521147||NCI|Published by the College of American Pathologists, the Systematized Nomenclature of Medicine Clinical Terms is a combination of content of SNOMED Reference Terminology and READ codes.|N||
C1623497|A3621013|AT22534661||MSH|Combined content of reference terminology and READ codes.|N||
C1699030|A7419046|AT53147361||HL7V3.0|Digital Imaging and Communications in Medicine (DICOM) MIME type defined in RFC3240 [http://ietf.org/rfc/rfc3240.txt].|N||
C1699030|A7632961|AT56566653||NCI|A set of standard terms for communications regarding medical imaging.|N||
C1704269|A7552121|AT55404455||MSH|A low affinity interleukin-5 receptor subunit that combines with the CYTOKINE RECEPTOR COMMON BETA SUBUNIT to form a high affinity receptor for INTERLEUKIN-5. Several isoforms of the interleukin-5 receptor alpha subunit exist due to multiple ALTERNATIVE SPLICING.|N||
C1704269|A8687552|AT60873916||NCI|Interleukin-5 receptor subunit alpha (420 aa, 48 kD) is a cell division process protein that is encoded by the human IL5RA gene and has roles in cell proliferation and signal transduction.|N||
C1704338|A4252676|AT22515168||MSH|Used with diseases for all aspects of diagnosis, including examination, differential diagnosis and prognosis; excludes mass screening for which "prevention & control" is used. Excludes radiographic diagnosis for which "radiography" is used; excludes scintigraphic diagnosis for which "radionuclide imaging" is used; excludes ultrasonic diagnosis for which "ultrasonography" is used.|N||
C1706290|A7552075|AT55404506||MSH|A subunit of the interleukin-18 receptor that is responsible of extracellular binding of IL-18.|N||
C1706293|A7554816|AT55404447||MSH|Cell surface receptors that are specific for THROMBOPOIETIN. They signal through interaction with JANUS KINASES such as JANUS KINASE 2.|N||
C1706295|A7555850|AT55404241||MSH|A tumor necrosis factor receptor superfamily member found expressed on peripheral B-LYMPHOCYTES. It has specificity for B-CELL MATURATION ANTIGEN and TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13.|N||
C1706296|A7549280|AT55404882||MSH|A member of the tumor necrosis factor receptor superfamily that specifically binds B-CELL ACTIVATING FACTOR. It is found on B-LYMPHOCYTES and plays a role in maturation and survival of B-cells. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.|N||
C1706415|A7552105|AT55404877||MSH|A low affinity interleukin-3 receptor subunit that combines with the CYTOKINE RECEPTOR COMMON BETA SUBUNIT to form a high affinity receptor for INTERLEUKIN-3.|N||
C1706563|A7552076|AT55403940||MSH|A subunit of the interleukin-18 receptor that plays a role in receptor signaling by association of its cytoplasmic domain with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88.|N||
C1721038|A7552111|AT55404461||MSH|A receptor subunit that is a component of the TYPE I INTERLEUKIN-4 RECEPTOR and the TYPE II INTERLEUKIN-4 RECEPTOR. It signals through interaction of its cytoplasmic domain with JANUS KINASES such as JANUS KINASE 1.|N||
C1721043|A7552500|AT55404923||MSH|A receptor subunit that combines with CYTOKINE RECEPTOR GP130 to form the dual specificity receptor for LEUKEMIA INHIBITORY FACTOR and ONCOSTATIN M. The subunit is also a component of the CILIARY NEUROTROPHIC FACTOR RECEPTOR. Both membrane-bound and secreted isoforms of the receptor subunit exist due to ALTERNATIVE SPLICING of its mRNA. The secreted isoform is believed to act as an inhibitory receptor, while the membrane-bound form is a signaling receptor.|N||
C1721045|A7552126|AT55404828||MSH|A low affinity interleukin-7 receptor subunit that combines with the INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT to form a high affinity receptor for INTERLEUKIN-7.|N||
C1721051|A7552023|AT55404395||MSH|A subunit of the interleukin-10 receptor. It plays a role in receptor signaling by associating with JANUS KINASE 1.|N||
C1721052|A7552024|AT55404655||MSH|A subunit of the interleukin-10 receptor. It plays a role in receptor signaling by associating with TYK2 KINASE.|N||
C1721056|A7554797|AT55404076||MSH|Cell surface receptors for INTERLEUKIN-17. Several subtypes of receptors have been found, each with its own in specificity for interleukin-17 subtype.|N||
C1739772|A8700372|AT60879929||MSH|A KIR receptor that has specificity for HLA-C ANTIGEN. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL2 RECEPTOR and the KIR2DL3 RECEPTOR.|N||
C1743029|A8700375|AT60879297||MSH|A KIR receptor that has specificity for HLA-B ANTIGEN. It is an inhibitory receptor that contains D0, D1, and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.|N||
C1743908|A8700373|AT60879324||MSH|A KIR receptor that has specificity for HLA-G antigen. It contains D0 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.|N||
C1744321|A8700371|AT60880518||MSH|A KIR receptor that has specificity for HLA-C ANTIGEN. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL1 RECEPTOR and the KIR2DL3 RECEPTOR.|N||
C1744322|A8700370|AT60879928||MSH|A KIR receptor that has specificity for HLA-C ANTIGEN. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL2 RECEPTOR and the KIR2DL3 RECEPTOR.|N||
CL033129|A2795050|AT18507905||NCI-GLOSS|PDQ. The Physician Data Query is an online database developed and maintained by the National Cancer Institute. Designed to make the most current, credible, and accurate cancer information available to health professionals and the public, PDQ contains peer-reviewed summaries on cancer treatment, screening, prevention, genetics, and supportive care; a registry of cancer clinical trials from around the world; and directories of physicians, professionals who provide genetics services, and organizations that provide cancer care. Most of this information is available on the Cancer.gov Web site. More specific information about PDQ can be found at http://cancer.gov/cancer_information/pdq/.|N||
CL051471|A0194626|AT16135249||CTEP|CTEP_For_FDA: 10021510/Immunosuppressive disorders|N||
CL051471|A2641464|AT60862017||NCI|A group of non-neoplastic and neoplastic disorders resulting from the deregulation and/or deficiency of immune system functions. It includes autoimmune disorders (e.g., lupus erythematosus, dermatomyositis, rheumatoid arthritis), congenital and acquired immunodeficiency syndromes including the acquired immune deficiency syndrome (AIDS), and neoplasms (e.g., lymphomas and malignancies secondary to transplantation.)|N||
CL101992|A2739549|AT18327803||NCI|Esterase Genes encode Esterases that catalyze hydrolysis of ester bonds to produce alcohol and acid reaction products. (NCI)|N||
CL102485|A2737966|AT18324034||NCI|Enzyme Genes encode Enzymes, biological molecules (usually proteins) that possess catalytic activity. Catalytic RNA and catalytic DNA molecules have also been identified. (NCI)|N||
CL104089|A2654383|AT60845589||NCI|An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The MedDRA Maintenance and Support Services Organization holds a contract with the International Federation of Pharmaceutical Manufacturers Associations to maintain and support the implementation of the terminology.|N||
CL104089|A2801310|AT52061972||CDISC|MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI)|N||
CL321731|A2637081|AT50092149||NCI|Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs.|N||
CL321731|A6871729|AT52061561||CDISC|Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs. (NCI)|N||
CL324467|A0563264|AT43093121||CTEP|CTEP_For_FDA: 90600296/Non-neoplastic condition|N||
CL324467|A5864966|AT50092098||NCI|Any disorder other than abnormal tissue growth resulting from uncontrolled cell proliferation.|N||
CL331289|A2750102|AT18488065||NCI|Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.|N||
CL360522|A5891391|AT43121591||NCI|An information system, RENI (REgistry Nomenclature Information System) is the extended electronic version of the publications 'International Classification of Rodent Tumours'. The system was initially developed to support the RITA (Registry of Industrial Toxicology Animal-data) project, however, since 1998 it is accessible via the Internet. Besides the nomenclature and diagnostic criteria, RENI contains more than 1,500 histopathological images and for most of the references direct links to the corresponding abstracts in PUBMED are provided. (from RITA)|N||
CL369490|A7062015|AT52063985||MGED|The MGED Ontology is a top level container for the MGEDCoreOntology and the MGEDExtendedOntology. The MGED ontology describes microarray experiments and is split into the MGEDCoreOntology, which supports MAGE-OM v1.0 and is organized consistently with MAGE, and the MGEDExtendedOntology, which expands MAGE v1.0 and contains concepts and relationships which are not included in MAGE.|N||
CL385597|A5774880|AT22532286||MSH|Used with organs, regions, and tissues for normal descriptive anatomy and histology, and for the normal anatomy and structure of animals and plants.|N||
CL385598|A5784826|AT22527359||MSH|Used with drugs, biological preparations, and physical agents for their use in the prophylaxis and treatment of disease. It includes veterinary use.|N||
CL385636|A5698347|AT22528487||MSH|Used with bacteria, viruses, fungi, protozoa, and helminths for the obtaining of pure strains or for the demonstration of the presence of or identification of organisms by DNA analyses, immunologic, or other methods, including culture techniques. It is used also with biological substances and chemicals for the isolation and purification of the constituents.|N||
CL386023|A3380919|AT22514673||MSH|Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a choline moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and choline and 2 moles of fatty acids.|N||
CL388268|A8900463|AT63372316||CDISC|A measurement of the 5'-nucleotidase in a biological specimen|N||
CL388268|A8901301|AT63373451||NCI|The determination of the amount of 5 prime nucleotidase present in a sample.|N||
